<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?subarticle pcbi.1010961.r001?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLOS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10057851</article-id>
    <article-id pub-id-type="pmid">36930671</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-22-01320</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Protein Complexes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Oncology</subject>
          <subj-group>
            <subject>Cancers and Neoplasms</subject>
            <subj-group>
              <subject>Lung and Intrathoracic Tumors</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Biological Databases</subject>
            <subj-group>
              <subject>Proteomic Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteomics</subject>
            <subj-group>
              <subject>Proteomic Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Proteomes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Molecular Biology</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Molecular Biology Assays and Analysis Techniques</subject>
              <subj-group>
                <subject>Gene Expression and Vector Techniques</subject>
                <subj-group>
                  <subject>Protein Expression</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Molecular Biology Techniques</subject>
          <subj-group>
            <subject>Molecular Biology Assays and Analysis Techniques</subject>
            <subj-group>
              <subject>Gene Expression and Vector Techniques</subject>
              <subj-group>
                <subject>Protein Expression</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and analysis methods</subject>
        <subj-group>
          <subject>Biological cultures</subject>
          <subj-group>
            <subject>Cell lines</subject>
            <subj-group>
              <subject>HeLa cells</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and analysis methods</subject>
        <subj-group>
          <subject>Biological cultures</subject>
          <subj-group>
            <subject>Cell cultures</subject>
            <subj-group>
              <subject>Cultured tumor cells</subject>
              <subj-group>
                <subject>HeLa cells</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Post-Translational Modification</subject>
              <subj-group>
                <subject>Signal Peptides</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pharmacology</subject>
          <subj-group>
            <subject>Drug Research and Development</subject>
            <subj-group>
              <subject>Drug Discovery</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ProInfer: An interpretable protein inference tool leveraging on biological networks</article-title>
      <alt-title alt-title-type="running-head">ProInfer: An interpretable protein inference tool</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5137-1827</contrib-id>
        <name>
          <surname>Peng</surname>
          <given-names>Hui</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wong</surname>
          <given-names>Limsoon</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Goh</surname>
          <given-names>Wilson Wen Bin</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>School of Biological Sciences, Nanyang Technological University, Singapore, Singapore</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Department of Computer Science, National University of Singapore, Singapore, Singapore</addr-line>
    </aff>
    <aff id="aff004">
      <label>4</label>
      <addr-line>Center for Biomedical Informatics, Nanyang Technological University, Singapore, Singapore</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Elofsson</surname>
          <given-names>Arne</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Stockholm University: Stockholms Universitet, SWEDEN</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>wongls@comp.nus.edu.sg</email> (LW); <email>wilsongoh@ntu.edu.sg</email> (WWBG)</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <volume>19</volume>
    <issue>3</issue>
    <elocation-id>e1010961</elocation-id>
    <history>
      <date date-type="received">
        <day>5</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>20</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 Peng et al</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Peng et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pcbi.1010961.pdf"/>
    <abstract>
      <p>In mass spectrometry (MS)-based proteomics, protein inference from identified peptides (protein fragments) is a critical step. We present ProInfer (Protein Inference), a novel protein assembly method that takes advantage of information in biological networks. ProInfer assists recovery of proteins supported only by ambiguous peptides (a peptide which maps to more than one candidate protein) and enhances the statistical confidence for proteins supported by both unique and ambiguous peptides. Consequently, ProInfer rescues weakly supported proteins thereby improving proteome coverage. Evaluated across THP1 cell line, lung cancer and RAW267.4 datasets, ProInfer always infers the most numbers of true positives, in comparison to mainstream protein inference tools Fido, EPIFANY and PIA. ProInfer is also adept at retrieving differentially expressed proteins, signifying its usefulness for functional analysis and phenotype profiling. Source codes of ProInfer are available at <ext-link xlink:href="https://github.com/PennHui2016/ProInfer" ext-link-type="uri">https://github.com/PennHui2016/ProInfer</ext-link>.</p>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>Protein inference is a key step in proteomics data analysis. However, this procedure suffers from coverage issues due to high statistical stringency requirement and noise. Integration of prior knowledge to guide protein assembly can be a powerful approach. Hence, we developed a novel protein inference tool ProInfer that incorporates a length-adjusted and weighted-accumulated posterior error probability score with protein-complex networks. Compared against existing tools, ProInfer achieves the highest recall and F1 score in protein inference and also identifies novel differentially expressed proteins not reported by any other tool.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001459</institution-id>
            <institution>Ministry of Education - Singapore</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MOE2019-T2-1-042</award-id>
        <principal-award-recipient>
          <name>
            <surname>Goh</surname>
            <given-names>Wilson Wen Bin</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001459</institution-id>
            <institution>Ministry of Education - Singapore</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MOE2019-T2-1-042</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wong</surname>
            <given-names>Limsoon</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001459</institution-id>
            <institution>Ministry of Education - Singapore</institution>
          </institution-wrap>
        </funding-source>
        <award-id>RT11/21</award-id>
        <principal-award-recipient>
          <name>
            <surname>Goh</surname>
            <given-names>Wilson Wen Bin</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This work was supported by the Ministry of Education Singapore via an AcRF Tier 2 award (MOE2019-T2-1-042 to WWBG and LW) and a AcRF Tier 1 award RT11/21 to WWBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="3"/>
      <table-count count="1"/>
      <page-count count="19"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2023-03-29</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All relevant data are within the manuscript and its <xref rid="sec019" ref-type="sec">Supporting Information</xref> files.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All relevant data are within the manuscript and its <xref rid="sec019" ref-type="sec">Supporting Information</xref> files.</p>
  </notes>
</front>
<body>
  <disp-quote>
    <p>This is a <italic toggle="yes">PLOS Computational Biology</italic> Methods paper.</p>
  </disp-quote>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>Contemporary mass spectrometry (MS)-based proteomics is characterized by advanced high-throughput technologies for identifying proteins from complex mixtures [<xref rid="pcbi.1010961.ref001" ref-type="bibr">1</xref>–<xref rid="pcbi.1010961.ref002" ref-type="bibr">2</xref>]. MS proteomics measures the mass-to-charge (m/z) ion ratios, retention times, and ion intensities of precursor ions and peptide fragments [<xref rid="pcbi.1010961.ref003" ref-type="bibr">3</xref>–<xref rid="pcbi.1010961.ref004" ref-type="bibr">4</xref>]. A complex multi-step analytical procedure is then performed to reverse-engineer spectral information into peptide sequences (peptide-spectrum matching), followed by re-assembly of peptides to constituent proteins. The process of estimating the optimal set of proteins given acquired spectra is known as the protein inference problem [<xref rid="pcbi.1010961.ref005" ref-type="bibr">5</xref>–<xref rid="pcbi.1010961.ref007" ref-type="bibr">7</xref>]. Quantitative analysis is then performed to identify phenotype-specific proteins [<xref rid="pcbi.1010961.ref008" ref-type="bibr">8</xref>], obtain their function annotation [<xref rid="pcbi.1010961.ref009" ref-type="bibr">9</xref>] and determine potential applications in clinical [<xref rid="pcbi.1010961.ref010" ref-type="bibr">10</xref>] and medical settings [<xref rid="pcbi.1010961.ref011" ref-type="bibr">11</xref>] (<bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1A</xref></bold>).</p>
    <fig position="float" id="pcbi.1010961.g001">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1010961.g001</object-id>
      <label>Fig 1</label>
      <caption>
        <title>Workflow for protein inference and differential expression analysis with proteomic data and hyperparameter optimization results of proposed ProInfer.</title>
        <p>A shows a simple workflow of proteomics data-based protein inference and differential expression analysis. B gives a schema diagram of how ProInfer works. C presents the average inferred protein numbers and numbers of true positives found by ProInfer under different psm filtering thresholds (y-axis). The curves in D illustrate the performances of ProInfer indicated by recall, F1 (left-y axis) and precision (right-y axis) affected by various psm filtering thresholds (x-axis).</p>
      </caption>
      <graphic xlink:href="pcbi.1010961.g001" position="float"/>
    </fig>
    <p>In peptide-spectrum matching, a spectrum is matched against peptides in both a reference and a decoy protein sequence database, producing a score for each peptide-spectrum match (PSM) [<xref rid="pcbi.1010961.ref012" ref-type="bibr">12</xref>]. Given these PSMs, one can perform peptide identification, i.e., distinguishing correct PSM from incorrect ones, with well-known tools such as PeptideProphet [<xref rid="pcbi.1010961.ref013" ref-type="bibr">13</xref>] and Percolator [<xref rid="pcbi.1010961.ref014" ref-type="bibr">14</xref>]. Percolator was shown to identify more PSMs under similar q-value thresholds [<xref rid="pcbi.1010961.ref014" ref-type="bibr">14</xref>]. It can output q-values and posterior error probability scores (PEP) for identified peptides. Briefly, a q-value is the minimal false discovery rate (FDR) threshold needed for a positive identification of a given peptide while a PEP score indicates the probability of incorrectly identifying a non-existing peptide [<xref rid="pcbi.1010961.ref015" ref-type="bibr">15</xref>]. PEP scores are reported in popular protein inference tools such as Fido [<xref rid="pcbi.1010961.ref016" ref-type="bibr">16</xref>], PIA (Protein Inference Algorithms) [<xref rid="pcbi.1010961.ref017" ref-type="bibr">17</xref>] and EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>].</p>
    <p>Protein inference is concerned with protein identification from identified peptides. Protein inference is a demanding task and is affected by experimental/biological and analytical challenges. Example experimental/biological challenges include incomplete proteome coverage due to high dynamic range of protein abundances, limitations in digestion and protein separability under experimental running conditions, and detector sensitivity and resolution [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>], whereas the algorithm design and assumption validity, parameter values, and sequence library completeness are example analytical challenges. A particularly cumbersome problem is dealing with peptide ambiguity where one peptide can be mapped to two or more proteins [<xref rid="pcbi.1010961.ref019" ref-type="bibr">19</xref>]. Proteome coverage issues can be eased by leveraging on alternative data acquisition strategies, e.g., parallel accumulation–serial fragmentation combined with data-independent acquisition (diaPASEF) [<xref rid="pcbi.1010961.ref020" ref-type="bibr">20</xref>], which increases precursor identification specificity. Peptide ambiguity problem is solved by either discarding ambiguous peptides (peptides which map to &gt; 1 protein), e.g., Percolator [<xref rid="pcbi.1010961.ref014" ref-type="bibr">14</xref>]; or conducting network analysis on peptide-protein bipartite networks, e.g., EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>]. Those proteins sharing the same constituent peptides may be reported as protein groups [<xref rid="pcbi.1010961.ref017" ref-type="bibr">17</xref>] in which case, we can be assured that at least 1 member in the protein group exists. Protein inference is a critical problem for proteomics, and so, many such methods have been developed (please see Huang et al [<xref rid="pcbi.1010961.ref021" ref-type="bibr">21</xref>] for details regarding some early methods). Newer (and popular) protein inference methods include Percolator [<xref rid="pcbi.1010961.ref014" ref-type="bibr">14</xref>], Fido [<xref rid="pcbi.1010961.ref016" ref-type="bibr">16</xref>], PIA [<xref rid="pcbi.1010961.ref017" ref-type="bibr">17</xref>], EPIFANY[<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>] and ProteinProphet [<xref rid="pcbi.1010961.ref022" ref-type="bibr">22</xref>].</p>
    <p>Percolator [<xref rid="pcbi.1010961.ref014" ref-type="bibr">14</xref>] was originally designed for post-processing of peptide-spectrum matching results using semi-supervised learning. When protein inference is required, users may opt for a protein-level FDR threshold to output inferred proteins and their respective probabilities [<xref rid="pcbi.1010961.ref023" ref-type="bibr">23</xref>]. Perhaps to improve precision, Percolator does not consider ambiguous peptides, which may reduce proteome coverage. Fido [<xref rid="pcbi.1010961.ref016" ref-type="bibr">16</xref>] is a Bayesian probabilistic method for addressing ambiguous peptide problems and computing protein probabilities using graph-transforming algorithms. Fido creators claimed their method outperforms the heuristic posterior probability models based on expectation-maximization such as ProteinProphet [<xref rid="pcbi.1010961.ref022" ref-type="bibr">22</xref>]. PIA [<xref rid="pcbi.1010961.ref017" ref-type="bibr">17</xref>] is a consensus tool for integrating results of different search engines and different protein inference tools, e.g., ProteinProphet [<xref rid="pcbi.1010961.ref022" ref-type="bibr">22</xref>], Scaffold [<xref rid="pcbi.1010961.ref019" ref-type="bibr">19</xref>], and IDPicker [<xref rid="pcbi.1010961.ref024" ref-type="bibr">24</xref>]. PIA addresses ambiguous peptides by employing maximum parsimony principles and finding a minimal set of proteins explaining found peptides or PSMs [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>]. EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>] is a recently published protein inference tool that applies a loopy belief propagation algorithm (LBP) with convolution trees to process Bayesian networks. Via a peptide-protein bipartite graph, EPIFANY adopts convolution trees to propagate probabilities between peptides and proteins even for ambiguous peptides.</p>
    <p>While these popular tools play significant roles in protein inference, there is room for improvement, especially in reported protein accuracy and proteome coverage. Current protein inference methods generally report proteins with lower q-values (q-values in this scenario, is a rank-based metric for comparing confidences of inferred proteins being present [<xref rid="pcbi.1010961.ref015" ref-type="bibr">15</xref>]). Consequently, proteins that are in fact present but have lower peptide support are ignored. Unless approaches exist to exhaustively mine low quality spectra for peptide spectra matches (PSMs), we do not expect peptide information supporting each protein to change drastically. Given such constraints, we believe most current tools are reliant only on direct peptide-to-protein information, to attain an upper limit (albeit incomplete) on the observable proteome [<xref rid="pcbi.1010961.ref021" ref-type="bibr">21</xref>]. To overcome these information barriers, we believe incorporating prior knowledge via data integration, e.g., drawing from independent data sources such as biological networks, is essential. Hence, we propose a protein-length adjusted posterior error probability accumulation method <bold><italic toggle="yes">ProInfer</italic></bold> (short for Protein Inference), which features a comprehensive yet simple rule towards protein scoring (including how it handles peptide ambiguity). To help users, ProInfer’s methodology is easily understood; involving no complex calculations while possessing reasonable assumptions. Additionally, ProInfer borrows similar principles from our missing protein prediction method PROTREC [<xref rid="pcbi.1010961.ref025" ref-type="bibr">25</xref>] that leverages on the phenomenon that proteins forming a stable protein complex (or constituting part of a tightly clustered network module) are more likely to be co-expressed [<xref rid="pcbi.1010961.ref026" ref-type="bibr">26</xref>]. Specifically, it incorporates protein complex information to rescue proteins with weak signals themselves but have neighbors with strong evidence. ProInfer achieves excellent performance in both protein inference and downstream quantitative analysis.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Materials and methods</title>
    <sec id="sec003">
      <title>ProInfer</title>
      <p>A schematic of ProInfer is shown in <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1B</xref></bold>. ProInfer comprises three stages: protein inference from the peptide-protein network, protein complex inference and protein rescoring from the protein-complex network. To define these terms: A peptide-protein network refers to the connections of identified peptides to their host proteins. This information is vital to demonstrating existence of these proteins in the sample (see an example of a peptide-protein network in left side of <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1B</xref></bold>). Peptide-protein networks are useful for performing protein assembly from constituent peptides. Proteins work together as aggregates known as biological networks. These in turn, can be expressed as protein complexes or pathways, and is information rich. Thus, a protein-complex network (see the right-side bidirectional network in <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1B</xref></bold>) is composed of proteins aggregating into protein complexes (defined as groups of polypeptide chains linked by noncovalent protein-protein interactions [<xref rid="pcbi.1010961.ref027" ref-type="bibr">27</xref>]). An arrow from a protein pointing towards a protein complex denotes the protein belongs to that complex. And thus, the protein’s existence adds evidence supporting the presence of the complex in a tissue (i.e., protein complex inference process based on observed constituent proteins). Alternatively, an arrow from a protein complex to a protein propagates the existence probability of this complex to its constituent proteins, helping to re-evaluate our confidence in the protein’s existence in a tissue (i.e., protein rescoring).</p>
    </sec>
    <sec id="sec004">
      <title>Protein inference from peptide-protein network</title>
      <p>Our idea for protein inference from peptide-protein network stems originally from a need to address peptide ambiguity issues. Suppose an identified peptide <italic toggle="yes">Q</italic> from spectra is mappable to <italic toggle="yes">N</italic> proteins {<italic toggle="yes">P</italic><sub>1</sub>, <italic toggle="yes">P</italic><sub>2</sub>,…,<italic toggle="yes">P</italic><sub><italic toggle="yes">N</italic></sub>}. We may reasonably assume that Q has an equal chance to come from <italic toggle="yes">N</italic> candidate proteins.</p>
      <p>The false-reporting probability of using Q to support reporting <italic toggle="yes">P</italic><sub>1</sub> is the chance that <italic toggle="yes">Q</italic> is an incorrect identification (with PEP score of <italic toggle="yes">pep</italic><sub><italic toggle="yes">Q</italic></sub>) plus the chance that <italic toggle="yes">Q</italic> is not incorrect but does not come from <italic toggle="yes">P</italic><sub>1</sub> (i.e., it is from one of <italic toggle="yes">P</italic><sub>2</sub>,…,<italic toggle="yes">P</italic><sub><italic toggle="yes">N</italic></sub>). This may be expressed as:
<disp-formula id="pcbi.1010961.e001"><alternatives><graphic xlink:href="pcbi.1010961.e001.jpg" id="pcbi.1010961.e001g" position="anchor"/><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mi>Q</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mi>Q</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives><label>(1)</label></disp-formula>
where <italic toggle="yes">pep</italic><sub><italic toggle="yes">Q</italic></sub> is the PEP score of peptide Q and N is the number of mappable proteins.</p>
      <p><xref rid="pcbi.1010961.e001" ref-type="disp-formula">Eq 1</xref> can be rewritten as
<disp-formula id="pcbi.1010961.e002"><alternatives><graphic xlink:href="pcbi.1010961.e002.jpg" id="pcbi.1010961.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mi>Q</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives><label>(2)</label></disp-formula></p>
      <p>Here, the term (1 –<italic toggle="yes">pep</italic><sub><italic toggle="yes">Q</italic></sub>) ⋅ (1/<italic toggle="yes">N</italic>) means each candidate protein receives equal support, i.e., <italic toggle="yes">Q</italic>’s posterior probability (1 –<italic toggle="yes">pep</italic><sub><italic toggle="yes">Q</italic></sub>). In practice, <italic toggle="yes">Q</italic> should not arise equally from each candidate parent protein as “longer proteins are more likely to generate spurious matches than shorter ones” [<xref rid="pcbi.1010961.ref028" ref-type="bibr">28</xref>]. In other words, the support attributed by an ambiguous peptide towards the existence of a protein also depends on the protein’s length. Thus, to express this idea, we normalize the probability of <italic toggle="yes">Q</italic> from <italic toggle="yes">P</italic><sub>1</sub> by accounting for protein length. The error of using <italic toggle="yes">Q</italic> to support <italic toggle="yes">P</italic><sub>1</sub> can be modified to
<disp-formula id="pcbi.1010961.e003"><alternatives><graphic xlink:href="pcbi.1010961.e003.jpg" id="pcbi.1010961.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mi>Q</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mi mathvariant="normal">ф</mml:mi></mml:mrow></mml:math></alternatives><label>(3)</label></disp-formula>
where ф is a length-based adjustment and is computed as:
<disp-formula id="pcbi.1010961.e004"><alternatives><graphic xlink:href="pcbi.1010961.e004.jpg" id="pcbi.1010961.e004g" position="anchor"/><mml:math id="M4" display="block" overflow="scroll"><mml:mi mathvariant="normal">ф</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>h</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>)</mml:mo><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></alternatives><label>(4)</label></disp-formula>
where <italic toggle="yes">len</italic>(<italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>) is a function computing the length of protein <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>.</p>
      <p>Now we consider the problem of reporting a protein <italic toggle="yes">P</italic><sub>1</sub> to be present given supporting peptides {<italic toggle="yes">Q</italic><sub>1</sub>, <italic toggle="yes">Q</italic><sub>2</sub>,…<italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic></sub>,…,<italic toggle="yes">Q</italic><sub><italic toggle="yes">m</italic></sub>}. If a peptide <italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic></sub> supports a protein <italic toggle="yes">P</italic><sub>1</sub> uniquely, this peptide is considered “unique”. If a peptide <italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic></sub> supports n &gt; 1 proteins {<italic toggle="yes">P</italic><sub>1</sub>, <italic toggle="yes">P</italic><sub>2</sub>,…<italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>,…,<italic toggle="yes">P</italic><sub><italic toggle="yes">n</italic></sub>}, this peptide is considered “ambiguous”.</p>
      <p>The error of peptide <italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic></sub> supporting <italic toggle="yes">P</italic><sub>1</sub> can be context-driven (unique or ambiguous) as follows:
<disp-formula id="pcbi.1010961.e005"><alternatives><graphic xlink:href="pcbi.1010961.e005.jpg" id="pcbi.1010961.e005g" position="anchor"/><mml:math id="M5" display="block" overflow="scroll"><mml:mi>p</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mrow><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>q</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mi>ф</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>u</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives><label>(5)</label></disp-formula>
where ф is computed as shown in Eq (<xref rid="pcbi.1010961.e004" ref-type="disp-formula">4</xref>).</p>
      <p>We assume that peptide <italic toggle="yes">Q</italic><sub>1</sub> supporting <italic toggle="yes">P</italic><sub>1</sub> is independent of other peptides <italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic>,<italic toggle="yes">j</italic>≠1</sub> supporting <italic toggle="yes">P</italic><sub>1</sub>. The total errors of using {<italic toggle="yes">Q</italic><sub>1</sub>, <italic toggle="yes">Q</italic><sub>2</sub>,…<italic toggle="yes">Q</italic><sub><italic toggle="yes">j</italic></sub>,…,<italic toggle="yes">Q</italic><sub><italic toggle="yes">m</italic></sub>} to support <italic toggle="yes">P</italic><sub>1</sub> to be present can be computed by:
<disp-formula id="pcbi.1010961.e006"><alternatives><graphic xlink:href="pcbi.1010961.e006.jpg" id="pcbi.1010961.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mi>p</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mspace width="0.25em"/></mml:mrow><mml:mo>|</mml:mo><mml:mo>{</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>}</mml:mo><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mspace width="0.25em"/><mml:mi>f</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(6)</label></disp-formula></p>
      <p>To calculate the FDR, we transform the cumulative PEP score from (6) (denoted as <italic toggle="yes">accPEP</italic>) to a confidence score:
<disp-formula id="pcbi.1010961.e007"><alternatives><graphic xlink:href="pcbi.1010961.e007.jpg" id="pcbi.1010961.e007g" position="anchor"/><mml:math id="M7" display="block" overflow="scroll"><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn><mml:mo>∙</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mi>e</mml:mi><mml:mo>−</mml:mo><mml:mn>14</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(7)</label></disp-formula></p>
      <p>In (7), we spike a small value of 1e−14 to avoid errors where <italic toggle="yes">S</italic> becomes undefined (NaN) when accPEP is 0. We compute the FDR derived q-value for reported proteins in the same way as EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>]. Firstly, the reported <italic toggle="yes">L</italic> proteins are ranked by confidence scores (<italic toggle="yes">S</italic>) in descending order, i.e., {<italic toggle="yes">P</italic><sup><italic toggle="yes">r</italic>1</sup>, <italic toggle="yes">P</italic><sup><italic toggle="yes">r</italic>2</sup>,…,<italic toggle="yes">P</italic><sup><italic toggle="yes">rk</italic></sup>,…,<italic toggle="yes">P</italic><sup><italic toggle="yes">rL</italic></sup>}. Then, the q-value of <italic toggle="yes">P</italic><sup><italic toggle="yes">rL</italic></sup> is the FDR with the threshold of its confidence score calculated by
<disp-formula id="pcbi.1010961.e008"><alternatives><graphic xlink:href="pcbi.1010961.e008.jpg" id="pcbi.1010961.e008g" position="anchor"/><mml:math id="M8" display="block" overflow="scroll"><mml:mi>q</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mi>y</mml:mi><mml:mo>≥</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>∈</mml:mo><mml:mi>D</mml:mi></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:mo>|</mml:mo><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mi>y</mml:mi><mml:mo>≥</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>∈</mml:mo><mml:mi>T</mml:mi></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:mo>|</mml:mo><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:math></alternatives><label>(8)</label></disp-formula>
where <italic toggle="yes">x</italic> is the threshold, and |{<italic toggle="yes">y</italic>≥<italic toggle="yes">x</italic>, <italic toggle="yes">y</italic>∈<italic toggle="yes">D</italic>}| or |{<italic toggle="yes">y</italic>≥<italic toggle="yes">x</italic>, <italic toggle="yes">y</italic>∈<italic toggle="yes">T</italic>}| counts the number of decoy (D) or target proteins (T) with confidence scores no less than the threshold.</p>
      <p>For <italic toggle="yes">k</italic> ∈[<italic toggle="yes">L</italic>−1, 1],
<disp-formula id="pcbi.1010961.e009"><alternatives><graphic xlink:href="pcbi.1010961.e009.jpg" id="pcbi.1010961.e009g" position="anchor"/><mml:math id="M9" display="block" overflow="scroll"><mml:mi>q</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="italic">min</mml:mi></mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(9)</label></disp-formula></p>
      <p>Given these q-values, we can select an appropriate FDR, e.g., 1%, to report the proteins that qualify under this threshold. At FDR 1%, we expect 1 decoy protein (False Positive) per 100 correct target proteins (True Positive).</p>
    </sec>
    <sec id="sec005">
      <title>Protein complex inference and protein rescoring with protein-complex network</title>
      <p>Given only PSM information, we may easily reach the upper boundary of reportable proteins no matter how good the protein inference tool is. This is because these protein inference methods are ultimately dependent on spectra completeness and quality [<xref rid="pcbi.1010961.ref021" ref-type="bibr">21</xref>]. In a typical experiment setting, due to limitations in instrument sensitivity, protein abundance and protein sequence uniqueness, some proteins are only supported by weak signals (e.g., few supporting peptides and/or low confidence peptides), and thus, are difficult to observe. To rescue such proteins, and improve proteome coverage, we may “borrow” information from other important modalities (protein-protein interaction network [<xref rid="pcbi.1010961.ref029" ref-type="bibr">29</xref>], gene expression profiles [<xref rid="pcbi.1010961.ref030" ref-type="bibr">30</xref>], etc.) Biological network information encapsulated in the form of protein complexes is particularly valuable, possessing high biological information value [<xref rid="pcbi.1010961.ref031" ref-type="bibr">31</xref>], improving statistical reproducibility [<xref rid="pcbi.1010961.ref032" ref-type="bibr">32</xref>] and improving phenotype characterization [<xref rid="pcbi.1010961.ref033" ref-type="bibr">33</xref>]. Using protein complexes, we developed PROTREC [<xref rid="pcbi.1010961.ref025" ref-type="bibr">25</xref>], a tool for missing protein recovery, which outperforms other missing protein prediction methods. We hypothesize that protein complexes can also be useful for improving protein inference from peptide information. To test this idea, we use protein complex information in ProInfer.</p>
      <p>Suppose ProInfer (refers to the part described in the above section) outputs <italic toggle="yes">L</italic> candidate proteins and their accPEP scores and q-values denoted by:
<disp-formula id="pcbi.1010961.e010"><alternatives><graphic xlink:href="pcbi.1010961.e010.jpg" id="pcbi.1010961.e010g" position="anchor"/><mml:math id="M10" display="block" overflow="scroll"><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>|</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mo>[</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:mo>]</mml:mo><mml:mo>}</mml:mo></mml:math></alternatives><label>(10)</label></disp-formula></p>
      <p>We collected <italic toggle="yes">C</italic> reliable protein complexes and generated <italic toggle="yes">C</italic> decoy protein complexes by replacing the protein ids (e.g., sp|P41182) in each real complex with corresponding decoy protein ids (e.g., DECOY_sp|P41182). The complexes are denoted by:
<disp-formula id="pcbi.1010961.e011"><alternatives><graphic xlink:href="pcbi.1010961.e011.jpg" id="pcbi.1010961.e011g" position="anchor"/><mml:math id="M11" display="block" overflow="scroll"><mml:mi>C</mml:mi><mml:mi>p</mml:mi><mml:mi>x</mml:mi><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:mi>c</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msup><mml:mspace width="0.25em"/></mml:mrow><mml:mo>)</mml:mo><mml:mo>|</mml:mo><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mo>[</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mi>C</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mo>}</mml:mo></mml:math></alternatives><label>(11)</label></disp-formula>
where <italic toggle="yes">c</italic><sub><italic toggle="yes">j</italic></sub> is the <italic toggle="yes">j</italic>th known protein complex, and it contains <italic toggle="yes">X</italic> constituent proteins denoted by <inline-formula id="pcbi.1010961.e012"><alternatives><graphic xlink:href="pcbi.1010961.e012.jpg" id="pcbi.1010961.e012g" position="anchor"/><mml:math id="M12" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mi>c</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:msubsup><mml:mrow><mml:mi>c</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>c</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>c</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>}</mml:mo></mml:math></alternatives></inline-formula>.</p>
      <p>The following procedures describe the protein complex inference and integration of protein complex information in <italic toggle="yes">Cpxs</italic> with ProInfer’s outputs <italic toggle="yes">Pros</italic>:</p>
      <list list-type="simple">
        <list-item>
          <p><bold>Step1.</bold> Initialization. We initialize the probability of protein <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> being present in the sample as <italic toggle="yes">p</italic>(<italic toggle="yes">Pi</italic>) = 1−<italic toggle="yes">accPEP</italic><sub><italic toggle="yes">i</italic></sub>. For a given FDR <italic toggle="yes">f</italic>, ProInfer reports <italic toggle="yes">num0</italic> numbers of target proteins.</p>
        </list-item>
        <list-item>
          <p><bold>Step2.</bold> Protein complex inference. Calculate the probability of a protein complex <italic toggle="yes">c</italic><sub><italic toggle="yes">j</italic></sub> being present in the sample as the maximum probability of the subset proteins in this complex and in <italic toggle="yes">Pros</italic>, denoted by:</p>
        </list-item>
      </list>
      <p><disp-formula id="pcbi.1010961.e013"><alternatives><graphic xlink:href="pcbi.1010961.e013.jpg" id="pcbi.1010961.e013g" position="anchor"/><mml:math id="M13" display="block" overflow="scroll"><mml:mi>p</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mo>{</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:mi>a</mml:mi><mml:mo>∈</mml:mo><mml:mo>[</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>z</mml:mi></mml:mrow><mml:mo>]</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></alternatives><label>(12)</label></disp-formula>
where <italic toggle="yes">accPEP</italic><sub><italic toggle="yes">a</italic></sub> is the accPEP score of the <italic toggle="yes">a</italic>th protein in the subset <italic toggle="yes">cP</italic><sup><italic toggle="yes">j</italic></sup>∩<italic toggle="yes">Pros</italic>.</p>
      <list list-type="simple">
        <list-item>
          <p><bold>Step3.</bold> Calculate the probability of protein <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> in <italic toggle="yes">Pros</italic> being present in the sample according to protein complex information. Let {<italic toggle="yes">c</italic><sub>1</sub>, <italic toggle="yes">c</italic><sub>2</sub>,…,<italic toggle="yes">c</italic><sub><italic toggle="yes">Q</italic></sub>} be the <italic toggle="yes">Q</italic> complexes containing <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>, then the probability of <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> is computed as the maximum probability of {<italic toggle="yes">c</italic><sub>1</sub>, <italic toggle="yes">c</italic><sub>2</sub>,…,<italic toggle="yes">c</italic><sub><italic toggle="yes">Q</italic></sub>}:</p>
        </list-item>
      </list>
      <disp-formula id="pcbi.1010961.e014">
        <alternatives>
          <graphic xlink:href="pcbi.1010961.e014.jpg" id="pcbi.1010961.e014g" position="anchor"/>
          <mml:math id="M14" display="block" overflow="scroll">
            <mml:mi>p</mml:mi>
            <mml:mo>_</mml:mo>
            <mml:mi>c</mml:mi>
            <mml:mi>p</mml:mi>
            <mml:mi>x</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>P</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
            </mml:mrow>
            <mml:mo>)</mml:mo>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal">m</mml:mi>
            <mml:mi mathvariant="normal">a</mml:mi>
            <mml:mi mathvariant="normal">x</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:mi>p</mml:mi>
              <mml:mo>(</mml:mo>
              <mml:mrow>
                <mml:msub>
                  <mml:mrow>
                    <mml:mi>c</mml:mi>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mn>1</mml:mn>
                  </mml:mrow>
                </mml:msub>
              </mml:mrow>
              <mml:mo>)</mml:mo>
              <mml:mo>,</mml:mo>
              <mml:mi>p</mml:mi>
              <mml:mo>(</mml:mo>
              <mml:mrow>
                <mml:msub>
                  <mml:mrow>
                    <mml:mi>c</mml:mi>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mn>2</mml:mn>
                  </mml:mrow>
                </mml:msub>
              </mml:mrow>
              <mml:mo>)</mml:mo>
              <mml:mo>,</mml:mo>
              <mml:mo>…</mml:mo>
              <mml:mo>,</mml:mo>
              <mml:mi>p</mml:mi>
              <mml:mo>(</mml:mo>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>c</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>Q</mml:mi>
                </mml:mrow>
              </mml:msub>
              <mml:mo>)</mml:mo>
            </mml:mrow>
            <mml:mo>)</mml:mo>
          </mml:math>
        </alternatives>
        <label>(13)</label>
      </disp-formula>
      <p>If no protein complex contains <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>, then <italic toggle="yes">p</italic>_<italic toggle="yes">cpx</italic>(<italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>) = 0.</p>
      <list list-type="simple">
        <list-item>
          <p><bold>Step4.</bold> Update the probability of <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> being present in the sample. By comparing <italic toggle="yes">p</italic>(<italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>) with <italic toggle="yes">p</italic>_<italic toggle="yes">cpx</italic>(<italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub>), we update the probability of <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> being present in the sample as:</p>
        </list-item>
      </list>
      <disp-formula id="pcbi.1010961.e015">
        <alternatives>
          <graphic xlink:href="pcbi.1010961.e015.jpg" id="pcbi.1010961.e015g" position="anchor"/>
          <mml:math id="M15" display="block" overflow="scroll">
            <mml:mi>p</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>P</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
            </mml:mrow>
            <mml:mo>)</mml:mo>
            <mml:mo>′</mml:mo>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal">m</mml:mi>
            <mml:mi mathvariant="normal">a</mml:mi>
            <mml:mi mathvariant="normal">x</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:mi>p</mml:mi>
              <mml:mo>(</mml:mo>
              <mml:mrow>
                <mml:msub>
                  <mml:mrow>
                    <mml:mi>P</mml:mi>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mi>i</mml:mi>
                  </mml:mrow>
                </mml:msub>
              </mml:mrow>
              <mml:mo>)</mml:mo>
              <mml:mo>,</mml:mo>
              <mml:mi>p</mml:mi>
              <mml:mo>_</mml:mo>
              <mml:mi>c</mml:mi>
              <mml:mi>p</mml:mi>
              <mml:mi>x</mml:mi>
              <mml:mo>(</mml:mo>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>P</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
              <mml:mo>)</mml:mo>
            </mml:mrow>
            <mml:mo>)</mml:mo>
          </mml:math>
        </alternatives>
        <label>(14)</label>
      </disp-formula>
      <list list-type="simple">
        <list-item>
          <p><bold>Step5.</bold> Check whether we can now report new target proteins with given FDR <italic toggle="yes">f</italic>. From Step4, we get <inline-formula id="pcbi.1010961.e016"><alternatives><graphic xlink:href="pcbi.1010961.e016.jpg" id="pcbi.1010961.e016g" position="anchor"/><mml:math id="M16" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>′</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>. We transform <italic toggle="yes">accPEP</italic><sub><italic toggle="yes">i</italic></sub>′ to its confidence score via above Formula (<xref rid="pcbi.1010961.e007" ref-type="disp-formula">7</xref>). Then, via Formulas (<xref rid="pcbi.1010961.e008" ref-type="disp-formula">8</xref>) and (<xref rid="pcbi.1010961.e009" ref-type="disp-formula">9</xref>), we compute the q-value of <italic toggle="yes">P</italic><sub><italic toggle="yes">i</italic></sub> as <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub>′. <italic toggle="yes">Pros</italic> is updated as following formula:</p>
        </list-item>
      </list>
      <disp-formula id="pcbi.1010961.e017">
        <alternatives>
          <graphic xlink:href="pcbi.1010961.e017.jpg" id="pcbi.1010961.e017g" position="anchor"/>
          <mml:math id="M17" display="block" overflow="scroll">
            <mml:mi>P</mml:mi>
            <mml:mi>r</mml:mi>
            <mml:mi>o</mml:mi>
            <mml:mi>s</mml:mi>
            <mml:mo>=</mml:mo>
            <mml:mo>{</mml:mo>
            <mml:mrow>
              <mml:msub>
                <mml:mrow>
                  <mml:mo>(</mml:mo>
                  <mml:mi>P</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
              <mml:mo>,</mml:mo>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>a</mml:mi>
                  <mml:mi>c</mml:mi>
                  <mml:mi>c</mml:mi>
                  <mml:mi>P</mml:mi>
                  <mml:mi>E</mml:mi>
                  <mml:mi>P</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
              <mml:mo>′</mml:mo>
              <mml:mo>,</mml:mo>
              <mml:msub>
                <mml:mrow>
                  <mml:mi>q</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>i</mml:mi>
                </mml:mrow>
              </mml:msub>
              <mml:mo>′</mml:mo>
            </mml:mrow>
            <mml:mo>)</mml:mo>
            <mml:mo>|</mml:mo>
            <mml:mi>i</mml:mi>
            <mml:mo>∈</mml:mo>
            <mml:mo>[</mml:mo>
            <mml:mn>1</mml:mn>
            <mml:mo>,</mml:mo>
            <mml:mi>L</mml:mi>
            <mml:mo>]</mml:mo>
            <mml:mo>}</mml:mo>
          </mml:math>
        </alternatives>
        <label>(15)</label>
      </disp-formula>
      <p>With FDR <italic toggle="yes">f</italic>, <italic toggle="yes">num</italic> target proteins are reported. If <italic toggle="yes">num</italic> &gt; <italic toggle="yes">num0</italic>, then turn to <bold>Step1</bold>, otherwise output <italic toggle="yes">Pros</italic> and stop.</p>
      <p>Unlike PROTREC, ProInfer does not compute the probability of a protein complex being present in a biological sample based on the weighted probability of all observed constituent proteins [<xref rid="pcbi.1010961.ref025" ref-type="bibr">25</xref>]. ProInfer’s approach is based on calculating the maximum of constituent proteins posterior probability (PP) expressed as PP = 1—<italic toggle="yes">accPEP</italic>. We used protein complexes downloaded from CORUM 3.0 [<xref rid="pcbi.1010961.ref034" ref-type="bibr">34</xref>]. We compute the probability of a protein complex being present in the sample as the maximum probability of its proteins’ posterior probability measured by 1—<italic toggle="yes">accPEP</italic>. Then, we update the posterior probability of a protein being present with the higher value compared between the protein’s original PP value and its parent complexes’ posterior probabilities, i.e., max(original PP, complexes’ PPs). For decoy proteins, PP derived from corresponding decoy complexes will be used (similarly, calculated by max(original PP, complexes’ PPs)). A decoy complex is constructed by replacing target proteins in its twin true complex with decoy ones. The introduction of decoy complexes is to make the inference of both target proteins and decoy proteins in a similar way to avoid bias in estimating FDR. This propagation procedure is iterated until no additional target proteins are reported under a given FDR.</p>
    </sec>
    <sec id="sec006">
      <title>Hyperparameter optimization and datasets</title>
      <p>Protein inference is conducted following peptide identification, where PSMs are evaluated and then filtered by a given PEP threshold. Retained PSMs are regarded as reliable. A strict PEP threshold retains high confidence PSMs but also produces many false negatives. Conversely, relaxed PEP thresholds alleviate the false negative problem but at the cost of introducing more false positives. Different tools adopt different strategies for threshold optimization.</p>
      <p>Tools such as EPIFANY, Fido and PIA have some tool-specific hyperparameters to be tuned, e.g., greedy group resolution for EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>] and Fido [<xref rid="pcbi.1010961.ref016" ref-type="bibr">16</xref>], regularization type for EPIFANY [<xref rid="pcbi.1010961.ref018" ref-type="bibr">18</xref>], and input score type and scoring method for PIA [<xref rid="pcbi.1010961.ref017" ref-type="bibr">17</xref>]. For a fair comparison, we optimized their hyperparameters with the same Hela cell line dataset initially. The Hela cell line, derived from cervical cancer cells, is the oldest and most used human cell line [<xref rid="pcbi.1010961.ref035" ref-type="bibr">35</xref>]; it is well-documented and widely applied in biochemical, biological, and medical experiments [<xref rid="pcbi.1010961.ref036" ref-type="bibr">36</xref>]. 4-replicates Hela cell line raw data of Mehta et al [<xref rid="pcbi.1010961.ref037" ref-type="bibr">37</xref>] were downloaded from PRIDE [<xref rid="pcbi.1010961.ref038" ref-type="bibr">38</xref>] with Project ID PXD022448 (see <bold><xref rid="pcbi.1010961.t001" ref-type="table">Table 1</xref></bold>).</p>
      <table-wrap position="float" id="pcbi.1010961.t001">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1010961.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Summary of datasets used for hyperparameter optimization and performance evaluation.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="pcbi.1010961.t001" id="pcbi.1010961.t001g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="center" rowspan="1" colspan="1">Dataset</th>
                <th align="center" rowspan="1" colspan="1">Condition</th>
                <th align="center" rowspan="1" colspan="1">Replicates/Samples</th>
                <th align="center" rowspan="1" colspan="1">PRIDE ID</th>
                <th align="center" rowspan="1" colspan="1">Purpose</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1">Hela</td>
                <td align="center" rowspan="1" colspan="1">-</td>
                <td align="center" rowspan="1" colspan="1">DDA1,DDA2,DDA3,DDA3</td>
                <td align="center" rowspan="1" colspan="1">PXD022448</td>
                <td align="center" rowspan="1" colspan="1">hyperparameter optimization</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">THP1</td>
                <td align="center" rowspan="1" colspan="1">M0</td>
                <td align="center" rowspan="1" colspan="1">M0_1, M0_2, M0_3</td>
                <td align="center" rowspan="1" colspan="1">PXD019800</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">THP1</td>
                <td align="center" rowspan="1" colspan="1">M1</td>
                <td align="center" rowspan="1" colspan="1">M1_1, M1_2, M1_3</td>
                <td align="center" rowspan="1" colspan="1">PXD019800</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">RAW264.7</td>
                <td align="center" rowspan="1" colspan="1">M0</td>
                <td align="center" rowspan="1" colspan="1">M0_1, M0_2, M0_3</td>
                <td align="center" rowspan="1" colspan="1">PXD019800</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">RAW264.7</td>
                <td align="center" rowspan="1" colspan="1">M1</td>
                <td align="center" rowspan="1" colspan="1">M1_1, M1_2, M1_3</td>
                <td align="center" rowspan="1" colspan="1">PXD019800</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">lung cancer</td>
                <td align="center" rowspan="1" colspan="1">Normal</td>
                <td align="center" rowspan="1" colspan="1">N24742,N31945,N32813_r,N35480</td>
                <td align="center" rowspan="1" colspan="1">PXD000853</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">lung cancer</td>
                <td align="center" rowspan="1" colspan="1">Patient</td>
                <td align="center" rowspan="1" colspan="1">T24742,T31945,T32813_r,T35480</td>
                <td align="center" rowspan="1" colspan="1">PXD000853</td>
                <td align="center" rowspan="1" colspan="1">Performance benchmarking</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>For performance benchmarking, the lung cancer data (lung cancer) of Li et al [<xref rid="pcbi.1010961.ref039" ref-type="bibr">39</xref>] (PXD000853), the THP1 cell line and RAW264.7 mouse macrophage cell line of Li et al [<xref rid="pcbi.1010961.ref040" ref-type="bibr">40</xref>] (PXD019800) were used. THP1 is a human leukemia monocytic cell line and is commonly studied for estimating modulation of monocyte and macrophage activities [<xref rid="pcbi.1010961.ref041" ref-type="bibr">41</xref>]. RAW264.7 is a mouse leukemia cell line of monocyte macrophage, where it has been extensively used to study macrophage functions, mechanisms, and signaling pathways [<xref rid="pcbi.1010961.ref037" ref-type="bibr">37</xref>,<xref rid="pcbi.1010961.ref042" ref-type="bibr">42</xref>]. The lung cancer data was adopted to discover new anticancer therapeutic targets [<xref rid="pcbi.1010961.ref039" ref-type="bibr">39</xref>] (see <bold><xref rid="pcbi.1010961.t001" ref-type="table">Table 1</xref></bold>).</p>
    </sec>
    <sec id="sec007">
      <title>Proteomic dataset processing</title>
      <p>Raw data were converted to.mzML format with MSConvert [<xref rid="pcbi.1010961.ref043" ref-type="bibr">43</xref>] and processed as per flowchart in <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1A</xref></bold>. MSFragger-3.4 [<xref rid="pcbi.1010961.ref044" ref-type="bibr">44</xref>] was used to conduct database search. A target-decoy searching strategy [<xref rid="pcbi.1010961.ref012" ref-type="bibr">12</xref>] was adopted where the protein database contains human reviewed proteins from UniProt [<xref rid="pcbi.1010961.ref045" ref-type="bibr">45</xref>] (UP000005640, downloaded in 5/5/2022) and known contaminants from the common Repository of Adventitious Proteins (cRAP, <ext-link xlink:href="https://www.thegpm.org/crap/" ext-link-type="uri">https://www.thegpm.org/crap/</ext-link>, added by FragPipe-17.1 [<xref rid="pcbi.1010961.ref044" ref-type="bibr">44</xref>], <ext-link xlink:href="https://fragpipe.nesvilab.org/" ext-link-type="uri">https://fragpipe.nesvilab.org/</ext-link>) database together with the decoy proteins generated by sequence reversal. Search parameters are as follows: precursor mass tolerance (PMT) of 20ppm, fragment mass tolerance (FMT) of 0.05Da, and peptide length of 7 to 50 (remaining parameters are left as default). Prior to inputting to different protein inference tools, we performed peptide indexing and feature extraction with OpenMS (version 2.7.0) [<xref rid="pcbi.1010961.ref046" ref-type="bibr">46</xref>] for Percolator, which was then used to conduct peptide identification with PEP scores computed for each PSM. With these scored PSMs, hyperparameters were optimized with grid search: PSM filtering thresholds (PSMs with PEP scores bigger than the threshold are dropped) were ranged among [0.01, 0.05, 0.1, 0.25, 0.5, 0.75, 0.999], while for other tool-specific hyperparameters, all possible values are tested.</p>
    </sec>
    <sec id="sec008">
      <title>Validation and performance evaluation</title>
      <p>The protein-expression tissue database, Human Protein Atlas (HPA) [<xref rid="pcbi.1010961.ref047" ref-type="bibr">47</xref>], is used for protein validation. HPA (<ext-link xlink:href="https://www.proteinatlas.org/" ext-link-type="uri">https://www.proteinatlas.org/</ext-link>) is a manually curated database that collects human proteins in cells, tissues, and organs via integrating various omics technologies such as antibody-based imaging, MS-based proteomics, transcriptomics, and systems biology [<xref rid="pcbi.1010961.ref047" ref-type="bibr">47</xref>]. Positive proteins for Hela cell line were downloaded (data were downloaded from <ext-link xlink:href="https://www.proteinatlas.org/search/NOT+celline_category_rna%3AHeLa%3BNot+detected" ext-link-type="uri">https://www.proteinatlas.org/search/NOT+celline_category_rna%3AHeLa%3BNot+detected</ext-link>). Proteins having UniProt ids [<xref rid="pcbi.1010961.ref045" ref-type="bibr">45</xref>] were retained. For Hela cell line, there are 11806 validated proteins (See detail protein list in <bold><xref rid="pcbi.1010961.s004" ref-type="supplementary-material">S4 Table</xref></bold>). We label the proteins predicted by different protein inference tools, e.g., our ProInfer, EPIFANY, etc., and validated by the Human Protein Atlas as true positives, otherwise they are considered false positives. We calculate several metrics for evaluating competing tools and optimizing their hyperparameters including inferred protein numbers, numbers of true positives, recall, precision and F1 score. Recall, precision and F1 score are given by:
<disp-formula id="pcbi.1010961.e018"><alternatives><graphic xlink:href="pcbi.1010961.e018.jpg" id="pcbi.1010961.e018g" position="anchor"/><mml:math id="M18" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives><label>(16)</label></disp-formula>
<disp-formula id="pcbi.1010961.e019"><alternatives><graphic xlink:href="pcbi.1010961.e019.jpg" id="pcbi.1010961.e019g" position="anchor"/><mml:math id="M19" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives><label>(17)</label></disp-formula>
<disp-formula id="pcbi.1010961.e020"><alternatives><graphic xlink:href="pcbi.1010961.e020.jpg" id="pcbi.1010961.e020g" position="anchor"/><mml:math id="M20" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mn>1</mml:mn><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>∙</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>∙</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives><label>(18)</label></disp-formula>
where, TP (true positive) refers to a protein reported by an inference tool, e.g., our ProInfer and validated by HPA, FN (false negative) means a protein in HPA but has not been reported by a given protein inference tool, and FP is a protein not in HPA but has been reported.</p>
      <p>The final performance evaluation of a tool is determined by the average performance across the 4-replicates’ Hela cell line data and varying protein reporting FDR among 0.005, 0.01, 0.025 and 0.05. F1 score is one of the most widely used metrics for measuring performance of a classifier and is used to select optimal hyperparameters.</p>
    </sec>
    <sec id="sec009">
      <title>Downstream differential expression analysis</title>
      <p>A simple differential expression analysis workflow is shown in <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1A</xref></bold>. This was used to benchmark protein inference tools by evaluating their ability to identify differentially expressed proteins. Taking the lung cancer data as an example, proteins differentially expressed in patient samples (4 biological replicates) when compared against normal samples, are expected to be identified. In each of the 8 samples, proteins are inferred by different tools with their matched spectra numbers being counted. An expression matrix for this lung cancer data is formed by integrating the 8 samples’ protein (final protein list is a union of all 8 samples) spectra counts where missing proteins are filled with counts of 0. We used this expression matrix as input to edgeR, a widely used differential expression analysis tool [<xref rid="pcbi.1010961.ref048" ref-type="bibr">48</xref>], to identify differentially expressed proteins. Those proteins with less than 2 non-missing values in samples of each condition are dropped. We define a differentially expressed protein (DEP) as the protein with absolute log2FC ≥ 0.585 (FC means fold change, equals to |FC| ≥ 1.5) and Benjamini &amp; Hochberg adjusted p-value (adj.pvalue) ≤ 0.05 [<xref rid="pcbi.1010961.ref049" ref-type="bibr">49</xref>].</p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec010">
    <title>Results</title>
    <sec id="sec011">
      <title>Summary of optimized hyperparameters with Hela cell line data</title>
      <p>We identified the optimal running conditions (or settings) for each tool (ProInfer, EPIFANY, Fido, Percolator and PIA) given data of a particular nature. This would allow us to compare the best outcomes possible for each tool.</p>
      <p>For each method, during hyperparameter optimization, we ranked their hyperparameters (or combinations of hyperparameters if more than one hyperparameter needs to be tuned) by corresponding average F1 scores across the 4-replicates Hela cell line data. And returned the best hyperparameter/combination.</p>
      <p><bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C and 1D</xref></bold> shows the hyperparameter optimization results of ProInfer. Only PSM filtering threshold (PEP) needs to be selected for ProInfer. Ostensibly, ProInfer has good resistance to low reliability PSMs: When a loose PSM filtering threshold is used, ProInfer achieves higher recall and F1 score with small decrease in precision. For example, when we set PSM filtering threshold as PEP ≤ 0.999, we increase coverage by ~400 more correct proteins in Hela cell line than filtering with PEP ≤ 0.01 (<bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref></bold>, 4595–4204). However, this comes at the cost of introducing ~300 more false positive proteins (<bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref></bold>, 4806–4512). When filtering with PSM PEP ≤ 0.25, the highest precision of 0.963 is obtained, which is 0.007 bigger than PEP ≤ 0.999 (0.956), but 0.02 less (<bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D</xref></bold>, 0.554–0.534) for recall and 0.021 less (<bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D</xref></bold>, 0.390–0.369) for F1 score. Notably, stricter filtering condition also eradicated many target peptides, resulting in the loss of signals that are potentially rescuable via integration with network information. Hence, a looser PSM filtering threshold for ProInfer is preferred. Accordingly, PSM PEP ≤ 0.999 is set as default hyperparameter for ProInfer in following tests.</p>
      <p>We tuned hyperparameters for EPIFANY, Fido, Percolator and PIA accordingly. EPIFANY works best when setting PSM PEP ≤ 0.05 and parameter greedy_group_resolution to be “remove_associations_only” and without regularize. For Fido, its optimal hyperparameters are: PSM PEP ≤ 0.1 and greedy_group_resolution setting as “true”. Like ProInfer, Percolator also works best with PSM PEP ≤ 0.999. For PIA, inference method of Spectrum Extractor, multiplicative scoring method and PSM PEP score are chosen, and PEP ≤ 0.999 is used. More details are found in <bold><xref rid="pcbi.1010961.s002" ref-type="supplementary-material">S2 Table</xref>.</bold></p>
    </sec>
    <sec id="sec012">
      <title>Benchmarking competing tools with THP1 cell line data</title>
      <p>We used the technical replicates of M0 THP1 (<bold><xref rid="pcbi.1010961.t001" ref-type="table">Table 1</xref></bold>) for conducting independent benchmarking. Positive proteins were obtained from HPA (11584 proteins, see <bold><xref rid="pcbi.1010961.s004" ref-type="supplementary-material">S4 Table</xref></bold>, data can be downloaded via <ext-link xlink:href="https://www.proteinatlas.org/search/NOT+celline_category_rna%3ATHP-1%3BNot+detected" ext-link-type="uri">https://www.proteinatlas.org/search/NOT+celline_category_rna%3ATHP-1%3BNot+detected</ext-link>). For each tool, optimal hyperparameters were determined as described above. The average performance across the 3 M0 THP1 replicates were used. In addition, an alternative positive protein set generated by filtering out proteins in HPA but without protein level evidence (with 11483 proteins) were also tested, minor performance differences were obtained, see <bold><xref rid="pcbi.1010961.s007" ref-type="supplementary-material">S7 Table</xref></bold> for more details.</p>
      <p>In <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold>, we showed the proportions of true positives (deep colors) against false positives (light colors). Protein reporting FDRs were set as 0.005, 0.01, 0.025 and 0.05 respectively. Regardless of FDR threshold, ProInfer reports the most numbers of true positives (albeit, with correspondingly more false positives as well). For instance, given FDR 0.01, ProInfer reports 5390 proteins in total, of which, 5041 are true positives. Compared against Percolator, 640 (<bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold>, 5041–4401) more true positives were reported with just 230 (<bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold>, 349–119) more false positives, achieving a 1:2.78 ratio of false positives:true positives gain (230:640). Similarly, the false positives:true positives gains comparing to EPIFANY, Fido and PIA are 1:2.90, 1:6.1 and 1:9.37. In addition, from <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold>, even with looser FDR thresholds, e.g., 0.025 and 0.05, ProInfer reports more true positives without incurring great changes to the presence of false positives (about 10 more false positives comparing to FDR 0.005 or 0.01). From <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2B</xref></bold>, ProInfer produces stable precisions while other tools acquire lower precisions as FDRs relaxes. In <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2C and 2D</xref></bold>, the line plots show that ProInfer always achieves the highest recall and F1 score. Notably, all methods obtain better recalls and F1 scores when FDR relaxes from 0.005 to 0.05. Amongst the methods, Percolator always gets highest precisions but lowest recalls and F1 scores.</p>
      <fig position="float" id="pcbi.1010961.g002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1010961.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Performance evaluation of various tools tested on 3 replicates of human THP1 dataset.</title>
          <p><bold>A</bold> shows average numbers of true positives (in deep colors) and false positives (in light colors) reported in 3 replicates of THP1 sample with FDR of 0.005, 0.01, 0.025 and 0.05 respectively with hyperparameters optimized with Hela data. <bold>B, C &amp; D</bold> show the changes of precision, recall and F1 values of competing tools under different protein reporting FDRs. <bold>E</bold> is a Venn diagram revealing the overlap of proteins reported by different tools and validation status of proteins that reported only by a specific tool.</p>
        </caption>
        <graphic xlink:href="pcbi.1010961.g002" position="float"/>
      </fig>
      <p>In <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2E</xref></bold>, we also used an upset plot to investigate overlaps among different methods’ reported proteins at FDR 0.01 in an example replicate of THP1 M0 cell line (refers to M0_1). We identified 4093 proteins commonly reported by all 5 tools. The overlap amongst competing tools is deep, making up at least 75% of total reported proteins (from 77% for ProInfer to 92% for Percolator). Almost all EPIFANY reported proteins are also reported by at least one tool. Notably, each of the remaining four tools can identify some proteins missed by others. Thus, we added an additional Venn diagram on top of the upset plot to show the reliability of these tool-unique proteins (<bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2E</xref></bold> inset). Amongst the 4093 commonly reported proteins, 4010 (98%) is validated by Human Protein Atlas (HPA detectable). Importantly, ProInfer identified the biggest number (1014) of uniquely reported proteins of which 776 out of 1014 (76.5%) were validated. PIA uniquely reported just 166 proteins, with 57.8% (96 out of 166) validated. Fido uniquely reported 83 proteins with less than half (38 out of 83) validated. For Percolator, the validation rate of its uniquely reported proteins is 85.7% (6/7), however the list size is very small in comparison. Hence, the superior performance of ProInfer to report many reliable proteins, not found by any other tool, makes it a promising tool to find novel protein biomarkers.</p>
    </sec>
    <sec id="sec013">
      <title>Evaluations of protein inference tools in differential expression analysis</title>
      <p>Following protein inference, downstream quantitative analysis is a key step for proteomics data analysis. To investigate how protein inference tools affect differential expression analysis, we used 3 published datasets for testing. FragPipe [<xref rid="pcbi.1010961.ref044" ref-type="bibr">44</xref>] and maxquant [<xref rid="pcbi.1010961.ref050" ref-type="bibr">50</xref>] are two popular platforms for proteome quantification, thus are tested for comparison.</p>
      <p>Bar plots in <bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3A</xref></bold>–<bold><xref rid="pcbi.1010961.g003" ref-type="fig">3C</xref></bold> present found DEP (in light colors) and non-DEP (in deep colors) numbers in human lung cancer, mouse RAW264.7 and human THP1 data by five protein inference tools, FragPipe and maxquant-based workflows. Given lung cancer and THP1 data, ProInfer reports the most proteins (including DEPs and Non-DEPs) comparing to other four protein inference tools and FragPipe or maxquant. In RAW264.7 data, PIA inferred the most proteins compared to other tools, however, ProInfer still found more proteins than other workflows except for PIA. For DEPs, FragPipe and maxquant always report more DEPs than these five protein inference tools except for the lung cancer data, where ProInfer identified about 20 more DEPs. This may be due to both FragPipe and maxquant adopting the match-between-runs (MBR) method to mitigate the missing value problem [<xref rid="pcbi.1010961.ref051" ref-type="bibr">51</xref>], where smaller missing rates will be obtained, e.g., about 15% for both FragPipe (15.11%) and maxquant (15.41%), but more than 19% for ProInfer (19.43%) and PIA (22.77%) averagely in THP1 M0 and M1 samples. ProInfer performs stably in protein reporting and DEP identification compared to other methods given the three tests.</p>
      <p>We are interested in how DEPs identified by different workflows overlap. In <bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3D</xref></bold>, an upset plot displays the intersections of DEPs found in lung cancer data by 7 workflows. 71 DEPs were reported by all 7 workflows, comprising 54% of all DEPs found by EPIFANY-based workflow (highest) and 32% of ProInfer-based workflow (lowest). All 7 workflows reported some unique DEPs, which is interesting. These unique DEPs may be valuable, e.g., novel biomarkers or drug targets. We drew an additional Venn diagram (<bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3D</xref></bold> inset) to check the validation status of these unique DEPs, where literature proofs were searched to prove they really associate with lung cancer. We searched literature by key words of given protein and lung cancer at first. Then we read the literature to check whether they reported any correlations between the protein and lung cancer. ProInfer found the largest number of uniquely reported DEPs, where 46 out of 60 of these DEPs can be validated by literature. Similarly, 44 DEPs were uniquely reported by Fido and 28 of them can be proved to play significant roles in lung cancer. For FragPipe and maxquant, 31 and 25 unique DEPs were confirmed and more than a half of them are supported by literature. In comparison, EPIFANY, PIA and percolator reported few unique DEPs. We listed the top 10 DEPs unique to ProInfer ranked by their adj.pvalues in <bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3E</xref></bold>. We can find published papers or recent preprints to confirm that these DEPs are lung cancer related. For example, the protein Fibulin-5 (Uniport id: Q9UBX5) is a product of gene FBLN5, which was reported to suppress lung cancer invasion by inhibiting matrix metalloproteinase-7 expression [<xref rid="pcbi.1010961.ref052" ref-type="bibr">52</xref>]. Pan et al. found that Dedicator of cytokinesis protein 1 (Uniport id: Q14185, product of gene DOCK1) plays significant role in cell migration, Akt expression, and vimentin phosphorylation and it’s a drug target for lung cancer [<xref rid="pcbi.1010961.ref053" ref-type="bibr">53</xref>]. However, these two important DEPs were missed by all other tools. More details about the literature proofs for these uniquely reported DEPs can be found in <bold><xref rid="pcbi.1010961.s003" ref-type="supplementary-material">S3 Table</xref></bold>. In addition, those unique DEPs with no existing evidence may be novel lung cancer related proteins. These examples show that ProInfer improves protein inference and DEP identification. It is thus useful for biomarker or drug target identification.</p>
      <fig position="float" id="pcbi.1010961.g003">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1010961.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Evaluation of methods on differential expression analysis.</title>
          <p>A, B &amp; C show the numbers of differentially expressed proteins (DEPs) and non-differentially expressed proteins (Non-DEPs) found by different protein inference tool-based, FragPipe and maxquant-based workflows from lung cancer, RAW264.7 and THP1 cell line data. D shows overlapping of DEPs reported by different workflows from lung cancer data and the validation status of those uniquely found DEPs. E gives the top10 example validation proofs of DEPs uniquely found by ProInfer.</p>
        </caption>
        <graphic xlink:href="pcbi.1010961.g003" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec014">
    <title>Discussion</title>
    <sec id="sec015">
      <title>Most protein assembly methods have limited coverage of underlying proteomes</title>
      <p>In HPA, there are 11584 confirmed proteins in THP1. Most protein inference methods except ProInfer, identified fewer than 5000 true positives even at a loose protein FDR of 0.05 (<bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold>). Percolator has the worst proteome coverage. This may be due to elimination of ambiguous peptides alongside a simple approach towards protein inference. Though, both ProInfer and other protein inference tools such as Percolator apply a loose PSM filtering threshold, i.e., PEP ≤ 0.999, ProInfer always achieves excellent performance in protein inference, where highest recalls and F1 scores are always obtained. This may means dropping low confidence peptides (including ambiguous peptides) too early adversely impact proteome coverage. Using biological networks, ProInfer is a successful method that can make good use of peptides with weaker signals (or with lower confidence that may be dropped by stricter filtering conditions) to achieve good proteome coverage.</p>
    </sec>
    <sec id="sec016">
      <title>While ProInfer dominates in our benchmarks, it does have drawbacks</title>
      <p>ProInfer works well on protein inference, especially when a looser peptide filtering criterion, e.g., PSM PEP ≤ 0.999, was applied. A strict filtering criterion may stave off more decoy peptides, which benefits some tools e.g., EPIFANY and Fido (see <bold><xref rid="sec010" ref-type="sec">Results</xref></bold>). However, such conservatism also results in widespread loss of informative target peptides, reducing proteome coverage. To manage noise from looser criteria, ProInfer integrates biological network information (e.g., protein complexes) to make good use of those peptides possessing relatively lower confidences to rescue more target proteins. In our evaluations, this strategy has proven effective in identifying more true positives than existing tools.</p>
      <p>However, ProInfer has several drawbacks:</p>
      <p>Firstly, ProInfer cannot manifest its full potential should biological networks be inapplicable or unavailable in the analytical context (e.g., when we don’t have enough reliable protein complexes or there is no complex network formable in the sample). In the current version of CORUM 3.0, there are 2916 curated human protein complexes, which is quite small, and does not account for all possible networks and complexes partook by all human proteins. The lack of a tissue-specific complexome database is a further limiting factor that we hope can be overcome eventually. Moreover, there are limited number of other species with well-characterized and extensive protein complex lists in this database; thus, unless homology mapping is an option, ProInfer may not work well on samples from other species (e.g., mouse, where PIA reports more proteins from mouse RAW264.7 cell line data).</p>
      <p>Secondly, we see potential for further optimization: The parameters may yet be further explored for ProInfer. For example, previously in a related study, we only used the complexes with size ≥ 5 to reduce instability issues [<xref rid="pcbi.1010961.ref025" ref-type="bibr">25</xref>]. Here, all curated complexes were used; if a threshold of 5 were used, many complexes would be unavailable, resulting in loss of many weak signal proteins. In future optimizations, we may study the impact of protein complex filtering on ProInfer performance. Moreover, during the calculation of protein complex existence probabilities, only a subset of proteins in a complex and in the candidate protein list (<italic toggle="yes">cP</italic><sup><italic toggle="yes">j</italic></sup>∩<italic toggle="yes">Pros</italic>) are considered. The low coverages of complexes may cause overestimation of the probabilities of complexes being present. However, if we filter out these low coverage proteins, then only a few complexes are usable, thus the performance of ProInfer also decreases. Other settings to be tuned includes how to better determine the probability of a complex to be present from its proteins and the signal propagation approach from complexes back to other same-complex proteins. Here, we simply assume the probability of a complex to be present equals to the <bold>maximum</bold> posterior probability of its proteins while the probability of a protein to be present from the complex side is measured as the <bold>maximum</bold> probability of all complexes containing it. In <bold><xref rid="pcbi.1010961.s005" ref-type="supplementary-material">S5 Table</xref></bold>, we tested setting a complex’s probability to be present as the <bold>mean</bold> posterior probability of its proteins. However smaller F1 scores are always achieved especially when a higher psm threshold is configured. Though using mean helps reduce false positive rates (within 1%), much more true positives are also dropped (~10%). Using maximum is currently an optimal selection, more advanced methods that help reduce false positives but keep true positives could be tried, e.g., calculate a prior probability of a complex to be present with enrichment test or our previous weighted probability method [<xref rid="pcbi.1010961.ref025" ref-type="bibr">25</xref>].</p>
      <p>Thirdly, for paralogous proteins that share the same peptides and can participate as mutually exclusive partners in protein complexes [<xref rid="pcbi.1010961.ref054" ref-type="bibr">54</xref>], ProInfer may possibly infer them as either simultaneously present or absent. This is because ProInfer is dependent on prior knowledge captured in the protein complex databases. It is possible to extend ProInfer by enriching protein complex data with information on gene expression and paralogs. This may reduce potential false positives.</p>
    </sec>
    <sec id="sec017">
      <title>Future work</title>
      <p>Our future work will focus on three aspects. Firstly, we may also try to incorporate tissue-specific expression gene information, e.g., from database TissGDB [<xref rid="pcbi.1010961.ref055" ref-type="bibr">55</xref>] and housekeeping gene information, e.g., from HRT Atlas [<xref rid="pcbi.1010961.ref056" ref-type="bibr">56</xref>], to help the identification of proteins with higher confidence of existence based on their biological functions. Such proteins can be accorded higher confidence scores even if their observable peptides present with low signals. Secondly, to cater for big data, we may implement ProInfer in more efficient programming languages, e.g., Scala [<xref rid="pcbi.1010961.ref057" ref-type="bibr">57</xref>] or C [<xref rid="pcbi.1010961.ref058" ref-type="bibr">58</xref>]. Finally, while we have evaluated across selective yet high-quality data, there are many new technological advances. Hence, we may further evaluate ProInfer on exciting new data such as single-cell proteomics [<xref rid="pcbi.1010961.ref059" ref-type="bibr">59</xref>] and spatial proteomics [<xref rid="pcbi.1010961.ref060" ref-type="bibr">60</xref>].</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec018">
    <title>Conclusion</title>
    <p>We propose a novel biological network-guided method ProInfer for performing protein inference. ProInfer maximizes use of peptide information (including ambiguous peptides) via a simple yet logical assignment rule. More importantly, biological networks, in the form of protein complexes, is integrated with ProInfer to rescue proteins with weak signals. In our evaluations, ProInfer is robust, and stable even across a wide range of conditions. This is in stark contrast to most other protein assembly tools which are sensitive to adjustments of filtering parameters (especially important since the optimal cutoff is often unknown). Critically, ProInfer can identify large numbers of validated novel proteins not found by any other tool. In our evaluations, we find that these novel proteins are phenotype relevant. Thus, ProInfer is promising for functional profiling and discovering novel biomarkers or drug targets. Source codes of ProInfer are publicly accessible at <ext-link xlink:href="https://github.com/PennHui2016/ProInfer" ext-link-type="uri">https://github.com/PennHui2016/ProInfer</ext-link>.</p>
  </sec>
  <sec id="sec019" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pcbi.1010961.s001" position="float" content-type="local-data">
      <label>S1 Table</label>
      <caption>
        <title>Data for generating figures in the main text.</title>
        <p>Sheets in S1_Table.xlsx with names “<xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref>” and “<xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D”</xref> show the tables containing the data for generating <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref></bold> and <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D</xref></bold> in our main text. Similarly, sheets “<xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref>” to “<xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2E</xref>” and “<xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3A</xref>” to “<xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3E</xref>” show the corresponding data for generating our <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref></bold> to <bold><xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2E</xref></bold> and <bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3A</xref></bold> to <bold><xref rid="pcbi.1010961.g003" ref-type="fig">Fig 3E</xref></bold> in main text respectively.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s001.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s002" position="float" content-type="local-data">
      <label>S2 Table</label>
      <caption>
        <title>Results of parameter optimization for competing protein inference tools.</title>
        <p>The five Sheets with names “supp.tab1” to “supp.tab5” show the parameter optimization results for EPIFANY, Fido, Percolator, PIA and ProInfer.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s002.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s003" position="float" content-type="local-data">
      <label>S3 Table</label>
      <caption>
        <title>Literature proofs for validating uniquely found differentially expressed proteins based on different protein inference tools.</title>
        <p>The seven sheets with names “supp.tab1” to “supp.tab7” show the literature proofs for validating uniquely found differentially expressed proteins based on five protein inference tools ProInfer, EPIFANY, Fido, Percolator, PIA and two quantification analysis platforms FragPipe and maxquant.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s003.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s004" position="float" content-type="local-data">
      <label>S4 Table</label>
      <caption>
        <title>Proteins obtained from the Human Protein Atlas for protein inference validation.</title>
        <p>Sheets “Hela detectable Protein in HPA” and “THP1 detectable Protein in HPA” contain the lists of detectable proteins in Hela and THP1 from the Human Protein Atlas for validating protein inference performances.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s004.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s005" position="float" content-type="local-data">
      <label>S5 Table</label>
      <caption>
        <title>Comparison of methods “mean” and “max” for calculating protein complex confidence scores.</title>
        <p>Sheet 1 shows the comparison results of using “mean” and “max” to calculate protein complex confidence scores.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s005.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s006" position="float" content-type="local-data">
      <label>S6 Table</label>
      <caption>
        <title>Results of testing the robustness of proposed ProInfer by removing pre-inferred proteins.</title>
        <p>Sheet 1 shows the testing of robustness of ProInfer by removing 5~50% of pre-inferred proteins.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s006.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pcbi.1010961.s007" position="float" content-type="local-data">
      <label>S7 Table</label>
      <caption>
        <title>The alternative validation data and the comparisons of validating inferred proteins with original validation data and the alternative validation data.</title>
        <p>Sheets “HPA_Hela_protein_level” and “HPA_THP1_protein_level” give the two alternative validation data by removing proteins without protein level evidence. Sheet “parameter optimization” shows the detail parameter optimization results of different protein inference tools based on the alternative validation data in sheet “HPA_Hela_protein_level”. The Sheets “<xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref>”, and “<xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D</xref>” show the minor changes in result data for generating our <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1C</xref></bold> and <bold><xref rid="pcbi.1010961.g001" ref-type="fig">Fig 1D</xref></bold> in main text when using the alternative validation data in sheet “HPA_Hela_protein_level”. Sheets with names “<xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2A</xref>” to “<xref rid="pcbi.1010961.g002" ref-type="fig">Fig 2E</xref>” show the minor changes when using the alternative validation data in sheet “HPA_THP1_protein_level” for performance tests of different protein inference tools.</p>
        <p>(XLSX)</p>
      </caption>
      <media xlink:href="pcbi.1010961.s007.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1010961.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Aebersold</surname><given-names>R</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>. <article-title>Mass spectrometry-based proteomics</article-title>. <source>Nature</source>. <year>2003</year>; <volume>422</volume>: <fpage>198</fpage>–<lpage>207</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature01511</pub-id><?supplied-pmid 12634793?><pub-id pub-id-type="pmid">12634793</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Ong</surname><given-names>SE</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>. <article-title>Mass spectrometry–based proteomics turns quantitative</article-title>. <source>Nat Chem Biol</source>. <year>2005</year>; <volume>1</volume>: <fpage>252</fpage>–<lpage>262</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nchembio736</pub-id><?supplied-pmid 16408053?><pub-id pub-id-type="pmid">16408053</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Jemal</surname><given-names>M.</given-names></name><article-title>High-throughput quantitative bioanalysis by LC/MS/MS</article-title>. <source>Biomed Chromatogr</source>. <year>2000</year>; <volume>14</volume>: <fpage>422</fpage>–<lpage>429</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/1099-0801(200010)14:6&amp;lt;422::AID-BMC25&amp;gt;3.0.CO;2-I</pub-id><?supplied-pmid 11002279?><pub-id pub-id-type="pmid">11002279</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>CC</given-names></name>, <name><surname>MacCoss</surname><given-names>MJ</given-names></name>. <article-title>Shotgun proteomics: tools for the analysis of complex biological systems</article-title>. <source>Curr Opin Mol Ther</source>. <year>2002</year>; <volume>4</volume>: <fpage>242</fpage>–<lpage>250</lpage>. <?supplied-pmid 12139310?><pub-id pub-id-type="pmid">12139310</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>. <article-title>Interpretation of shotgun proteomic data</article-title>. <source>Mol Cell Proteom</source>. <year>2005</year>; <volume>4</volume>: <fpage>1419</fpage>–<lpage>1440</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Webb-Robertson</surname><given-names>BJM</given-names></name>, <name><surname>Cannon</surname><given-names>WR</given-names></name>. <article-title>Current trends in computational inference from mass spectrometry-based proteomics</article-title>. <source>Brief Bioinform</source>. <year>2007</year>; <volume>8</volume>: <fpage>304</fpage>–<lpage>317</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbm023</pub-id><?supplied-pmid 17584764?><pub-id pub-id-type="pmid">17584764</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>The</surname><given-names>M</given-names></name>, <name><surname>Edfors</surname><given-names>F</given-names></name>, <name><surname>Perez-Riverol</surname><given-names>Y</given-names></name>, <name><surname>Payne</surname><given-names>SH</given-names></name>, <name><surname>Hoopmann</surname><given-names>MR</given-names></name>, <name><surname>Palmblad</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A protein standard that emulates homology for the characterization of protein inference algorithms</article-title>. <source>J Proteome Res</source>. <year>2018</year>; <volume>17</volume>: <fpage>1879</fpage>–<lpage>1886</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.jproteome.7b00899</pub-id><?supplied-pmid 29631402?><pub-id pub-id-type="pmid">29631402</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>de Lima-Souza</surname><given-names>RA</given-names></name>, <name><surname>Scarini</surname><given-names>JF</given-names></name>, <name><surname>Lavareze</surname><given-names>L</given-names></name>, <name><surname>Emerick</surname><given-names>C</given-names></name>, <name><surname>Crescencio</surname><given-names>LR</given-names></name>, <name><surname>Domingues</surname><given-names>RR</given-names></name>, <etal>et al</etal>. <article-title>Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma</article-title>. <source>Oral Dis</source>. <year>2021</year>; <volume>00</volume>: <fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/odi.14102</pub-id><?supplied-pmid 34902207?><pub-id pub-id-type="pmid">34902207</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Kustatscher</surname><given-names>G</given-names></name>, <name><surname>Grabowski</surname><given-names>P</given-names></name>, <name><surname>Schrader</surname><given-names>TA</given-names></name>, <name><surname>Passmore</surname><given-names>JB</given-names></name>, <name><surname>Schrader</surname><given-names>M</given-names></name>, <name><surname>Rappsilber</surname><given-names>J</given-names></name>. <article-title>Co-regulation map of the human proteome enables identification of protein functions</article-title>. <source>Nat Biotechnol</source>. <year>2019</year>; <volume>37</volume>: <fpage>1361</fpage>–<lpage>1371</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41587-019-0298-5</pub-id><?supplied-pmid 31690884?><pub-id pub-id-type="pmid">31690884</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Bhawal</surname><given-names>R</given-names></name>, <name><surname>Oberg</surname><given-names>AL</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Kohli</surname><given-names>M</given-names></name>. <article-title>Challenges and opportunities in clinical applications of blood-based proteomics in cancer</article-title>. <source>Cancers</source>. <year>2020</year>; <volume>12</volume>: <fpage>2428</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/cancers12092428</pub-id><?supplied-pmid 32867043?><pub-id pub-id-type="pmid">32867043</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Uzozie</surname><given-names>AC</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>. <article-title>Advancing translational research and precision medicine with targeted proteomics</article-title>. <source>J Proteomics</source>. <year>2018</year>; <volume>189</volume>: <fpage>1</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jprot.2018.02.021</pub-id><?supplied-pmid 29476807?><pub-id pub-id-type="pmid">29476807</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>JE</given-names></name>, <name><surname>Gygi</surname><given-names>SP</given-names></name>. <article-title>Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.</article-title><source>Nat Methods</source>. <year>2007</year>; <volume>4</volume>: <fpage>207</fpage>–<lpage>214</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth1019</pub-id><?supplied-pmid 17327847?><pub-id pub-id-type="pmid">17327847</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Keller</surname><given-names>A</given-names></name>, <name><surname>Nesvizhskii</surname><given-names>AI</given-names></name>, <name><surname>Kolker</surname><given-names>E</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>. <article-title>Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search</article-title>. <source>Anal Chem</source>. <year>2002</year>; <volume>74</volume>: <fpage>5383</fpage>–<lpage>5392</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/ac025747h</pub-id><?supplied-pmid 12403597?><pub-id pub-id-type="pmid">12403597</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Käll</surname><given-names>L</given-names></name>, <name><surname>Canterbury</surname><given-names>JD</given-names></name>, <name><surname>Weston</surname><given-names>J</given-names></name>, <name><surname>Noble</surname><given-names>WS</given-names></name>, <name><surname>MacCoss</surname><given-names>MJ</given-names></name>. <article-title>Semi-supervised learning for peptide identification from shotgun proteomics datasets</article-title>. <source>Nat Methods</source>. <year>2007</year>; <volume>4</volume>: <fpage>923</fpage>–<lpage>925</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth1113</pub-id><?supplied-pmid 17952086?><pub-id pub-id-type="pmid">17952086</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Käll</surname><given-names>L</given-names></name>, <name><surname>Storey</surname><given-names>JD</given-names></name>, <name><surname>MacCoss</surname><given-names>MJ</given-names></name>, <name><surname>Noble</surname><given-names>WS</given-names></name>. <article-title>Posterior error probabilities and false discovery rates: two sides of the same coin</article-title>. <source>J Proteome Res</source>. <year>2008</year>; <volume>7</volume>: <fpage>40</fpage>–<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/pr700739d</pub-id><?supplied-pmid 18052118?><pub-id pub-id-type="pmid">18052118</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Serang</surname><given-names>O</given-names></name>, <name><surname>MacCoss</surname><given-names>MJ</given-names></name>, <name><surname>Noble</surname><given-names>WS</given-names></name>. <article-title>Efficient marginalization to compute protein posterior probabilities from shotgun mass spectrometry data</article-title>. <source>J Proteome Res</source>. <year>2010</year>; <volume>9</volume>: <fpage>5346</fpage>–<lpage>5357</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/pr100594k</pub-id><?supplied-pmid 20712337?><pub-id pub-id-type="pmid">20712337</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Uszkoreit</surname><given-names>J</given-names></name>, <name><surname>Maerkens</surname><given-names>A</given-names></name>, <name><surname>Perez-Riverol</surname><given-names>Y</given-names></name>, <name><surname>Meyer</surname><given-names>HE</given-names></name>, <name><surname>Marcus</surname><given-names>K</given-names></name>, <name><surname>Stephan</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>PIA: an intuitive protein inference engine with a web-based user interface</article-title>. <source>J Proteome Res</source>. <year>2015</year>; <volume>14</volume>: <fpage>2988</fpage>–<lpage>2997</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00121</pub-id><?supplied-pmid 25938255?><pub-id pub-id-type="pmid">25938255</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Pfeuffer</surname><given-names>J</given-names></name>, <name><surname>Sachsenberg</surname><given-names>T</given-names></name>, <name><surname>Dijkstra</surname><given-names>TMH</given-names></name>, <name><surname>Serang</surname><given-names>O</given-names></name>, <name><surname>Reinert</surname><given-names>K</given-names></name>, <name><surname>Kohlbacher</surname><given-names>O</given-names></name>. <article-title>EPIFANY: A Method for Efficient High-Confidence Protein Inference</article-title>. <source>J Proteome Res</source>. <year>2020</year>; <volume>19</volume>: <fpage>1060</fpage>–<lpage>1072</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00566</pub-id><?supplied-pmid 31975601?><pub-id pub-id-type="pmid">31975601</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Searle</surname><given-names>BC</given-names></name>. <article-title>Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies</article-title>. <source>Proteomics</source>. <year>2010</year>; <volume>10</volume>: <fpage>1265</fpage>–<lpage>1269</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pmic.200900437</pub-id><?supplied-pmid 20077414?><pub-id pub-id-type="pmid">20077414</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Meier</surname><given-names>F</given-names></name>, <name><surname>Brunner</surname><given-names>AD</given-names></name>, <name><surname>Frank</surname><given-names>M</given-names></name>, <name><surname>Ha</surname><given-names>A</given-names></name>, <name><surname>Bludau</surname><given-names>I</given-names></name>, <name><surname>Voytik</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>diaPASEF: parallel accumulation–serial fragmentation combined with data-independent acquisition</article-title>. <source>Nat Methods</source>. <year>2020</year>; <volume>17</volume>: <fpage>1229</fpage>–<lpage>1236</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41592-020-00998-0</pub-id><?supplied-pmid 33257825?><pub-id pub-id-type="pmid">33257825</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Yu</surname><given-names>W</given-names></name>, <name><surname>He</surname><given-names>Z</given-names></name>. <article-title>Protein inference: a review</article-title>. <source>Brief Bioinform</source>. <year>2012</year>; <volume>13</volume>: <fpage>586</fpage>–<lpage>614</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbs004</pub-id><?supplied-pmid 22373723?><pub-id pub-id-type="pmid">22373723</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name>, <name><surname>Keller</surname><given-names>A</given-names></name>, <name><surname>Kolker</surname><given-names>E</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>. <article-title>A statistical model for identifying proteins by tandem mass spectrometry</article-title>. <source>Anal Chem</source>. <year>2003</year>; <volume>75</volume>: <fpage>4646</fpage>–<lpage>4658</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/ac0341261</pub-id><?supplied-pmid 14632076?><pub-id pub-id-type="pmid">14632076</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Savitski</surname><given-names>MM</given-names></name>, <name><surname>Wilhelm</surname><given-names>M</given-names></name>, <name><surname>Hahne</surname><given-names>H</given-names></name>, <name><surname>Kuster</surname><given-names>B</given-names></name>, <name><surname>Bantscheff</surname><given-names>M</given-names></name>. <article-title>A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets</article-title>. <source>Mol Cell Proteom</source>. <year>2015</year>; <volume>14</volume>: <fpage>2394</fpage>–<lpage>2404</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1074/mcp.M114.046995</pub-id><?supplied-pmid 25987413?><pub-id pub-id-type="pmid">25987413</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>ZQ</given-names></name>, <name><surname>Dasari</surname><given-names>S</given-names></name>, <name><surname>Chambers</surname><given-names>MC</given-names></name>, <name><surname>Litton</surname><given-names>MD</given-names></name>, <name><surname>Sobecki</surname><given-names>SM</given-names></name>, <name><surname>Zimmerman</surname><given-names>LJ</given-names></name>, <etal>et al</etal>. <article-title>IDPicker 2.0: Improved protein assembly with high discrimination peptide identification filtering</article-title>. <source>J Proteome Res</source>. <year>2009</year>; <volume>8</volume>: <fpage>3872</fpage>–<lpage>3881</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/pr900360j</pub-id><?supplied-pmid 19522537?><pub-id pub-id-type="pmid">19522537</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Kong</surname><given-names>W</given-names></name>, <name><surname>Wong</surname><given-names>BJH</given-names></name>, <name><surname>Gao</surname><given-names>H</given-names></name>, <name><surname>Guo</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Du</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>PROTREC: A probability-based approach for recovering missing proteins based on biological networks</article-title>. <source>J Proteomics</source>. <year>2022</year>; <volume>250</volume>: <fpage>104392</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jprot.2021.104392</pub-id><?supplied-pmid 34626823?><pub-id pub-id-type="pmid">34626823</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Fraser</surname><given-names>HB</given-names></name>, <name><surname>Hirsh</surname><given-names>AE</given-names></name>, <name><surname>Wall</surname><given-names>DP</given-names></name>, <name><surname>Eisen</surname><given-names>MB</given-names></name>. <article-title>Coevolution of gene expression among interacting proteins</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2004</year>; <volume>101</volume>: <fpage>9033</fpage>–<lpage>9038</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.0402591101</pub-id><?supplied-pmid 15175431?><pub-id pub-id-type="pmid">15175431</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Tolani</surname><given-names>P</given-names></name>, <name><surname>Gupta</surname><given-names>S</given-names></name>, <name><surname>Yadav</surname><given-names>K</given-names></name>, <name><surname>Aggarwal</surname><given-names>S</given-names></name>, <name><surname>Yadav</surname><given-names>AK</given-names></name>. <article-title>Big data, integrative omics and network biology</article-title>. <source>Adv Protein Chem Struct Biol</source>. <year>2021</year>; <volume>127</volume>: <fpage>127</fpage>–<lpage>160</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/bs.apcsb.2021.03.006</pub-id><?supplied-pmid 34340766?><pub-id pub-id-type="pmid">34340766</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>N</given-names></name>, <name><surname>Pevzner</surname><given-names>PA</given-names></name>. <article-title>False discovery rates of protein identifications: a strike against the two-peptide rule</article-title>. <source>J Proteome Res</source>. <year>2009</year>; <volume>8</volume>: <fpage>4173</fpage>–<lpage>4181</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/pr9004794</pub-id><?supplied-pmid 19627159?><pub-id pub-id-type="pmid">19627159</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Ramakrishnan</surname><given-names>SR</given-names></name>, <name><surname>Vogel</surname><given-names>C</given-names></name>, <name><surname>Kwon</surname><given-names>T</given-names></name>, <name><surname>Penalva</surname><given-names>LO</given-names></name>, <name><surname>Marcotte</surname><given-names>EM</given-names></name>, <name><surname>Miranker</surname><given-names>DP</given-names></name>. <article-title>Mining gene functional networks to improve mass-spectrometry-based protein identification</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>: <fpage>2955</fpage>–<lpage>2961</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btp461</pub-id><?supplied-pmid 19633097?><pub-id pub-id-type="pmid">19633097</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>TS</given-names></name>, <name><surname>Lucitt</surname><given-names>MB</given-names></name>, <name><surname>Wu</surname><given-names>W</given-names></name>, <name><surname>Austin</surname><given-names>DJ</given-names></name>, <name><surname>Pizarro</surname><given-names>A</given-names></name>, <name><surname>Yocum</surname><given-names>AK</given-names></name>, <etal>et al</etal>. <article-title>EBP, a program for protein identification using multiple tandem mass spectrometry datasets</article-title>. <source>Mol Cell Proteom</source>. <year>2007</year>; <volume>6</volume>: <fpage>527</fpage>–<lpage>536</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1074/mcp.T600049-MCP200</pub-id><?supplied-pmid 17164401?><pub-id pub-id-type="pmid">17164401</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Fraser</surname><given-names>HB</given-names></name>, <name><surname>Plotkin</surname><given-names>JB</given-names></name>. <article-title>Using protein complexes to predict phenotypic effects of gene mutation</article-title>. <source>Genome Biol</source>. <year>2007</year>; <volume>8</volume>: <fpage>1</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/gb-2007-8-11-r252</pub-id><?supplied-pmid 18042286?><pub-id pub-id-type="pmid">18042286</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Goh</surname><given-names>WWB</given-names></name>, <name><surname>Wong</surname><given-names>L</given-names></name>. <article-title>Evaluating feature-selection stability in next-generation proteomics</article-title>. <source>J Bioinform Comput Biol</source>. <year>2016</year>; <volume>14</volume>: <fpage>1650029</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1142/S0219720016500293</pub-id><?supplied-pmid 27640811?><pub-id pub-id-type="pmid">27640811</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Goh</surname><given-names>WWB</given-names></name>, <name><surname>Guo</surname><given-names>T</given-names></name>, <name><surname>Aebersold</surname><given-names>R</given-names></name>, <name><surname>Wong</surname><given-names>L</given-names></name>. <article-title>Quantitative proteomics signature profiling based on network contextualization</article-title>. <source>Biol Direct</source>. <year>2015</year>; <volume>10</volume>: <fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">25564011</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Giurgiu</surname><given-names>M</given-names></name>, <name><surname>Reinhard</surname><given-names>J</given-names></name>, <name><surname>Brauner</surname><given-names>B</given-names></name>, <name><surname>Dunger-Kaltenbach</surname><given-names>I</given-names></name>, <name><surname>Fobo</surname><given-names>G</given-names></name>, <name><surname>Frishman</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>CORUM: the comprehensive resource of mammalian protein complexes—2019</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>; <volume>47</volume>: <fpage>D559</fpage>–<lpage>D563</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky973</pub-id><?supplied-pmid 30357367?><pub-id pub-id-type="pmid">30357367</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Rahbari</surname><given-names>R</given-names></name>, <name><surname>Sheahan</surname><given-names>T</given-names></name>, <name><surname>Modes</surname><given-names>V</given-names></name>, <name><surname>Collier</surname><given-names>P</given-names></name>, <name><surname>Macfarlane</surname><given-names>C</given-names></name>, <name><surname>Badge</surname><given-names>RM</given-names></name>. <article-title>A novel L1 retrotransposon marker for HeLa cell line identification</article-title>. <source>Biotechniques</source>. <year>2009</year>; <volume>46</volume>: <fpage>277</fpage>–<lpage>284</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2144/000113089</pub-id><?supplied-pmid 19450234?><pub-id pub-id-type="pmid">19450234</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Fountoulakis</surname><given-names>M</given-names></name>, <name><surname>Tsangaris</surname><given-names>G</given-names></name>, <name><surname>Oh</surname><given-names>J</given-names></name>, <name><surname>Maris</surname><given-names>A</given-names></name>, <name><surname>Lubec</surname><given-names>G</given-names></name>. <article-title>Protein profile of the HeLa cell line</article-title>. <source>J Chromatogr A</source>. <year>2004</year>; <volume>1038</volume>: <fpage>247</fpage>–<lpage>265</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.chroma.2004.03.032</pub-id><?supplied-pmid 15233540?><pub-id pub-id-type="pmid">15233540</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Mehta</surname><given-names>D</given-names></name>, <name><surname>Scandola</surname><given-names>S</given-names></name>, <name><surname>Uhrig</surname><given-names>RG</given-names></name>. <article-title>BoxCar and Library-Free Data-Independent Acquisition Substantially Improve the Depth, Range, and Completeness of Label-Free Quantitative Proteomics</article-title>. <source>Anal Chem</source>. <year>2022</year>; <volume>94</volume>: <fpage>793</fpage>–<lpage>802</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.analchem.1c03338</pub-id><?supplied-pmid 34978796?><pub-id pub-id-type="pmid">34978796</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Vizcaíno</surname><given-names>JA</given-names></name>, <name><surname>Csordas</surname><given-names>A</given-names></name>, <name><surname>Del-Toro</surname><given-names>N</given-names></name>, <name><surname>Dianes</surname><given-names>JA</given-names></name>, <name><surname>Griss</surname><given-names>J</given-names></name>, <name><surname>Lavidas</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>2016 update of the PRIDE database and its related tools</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>; <volume>44</volume>: <fpage>D447</fpage>–<lpage>D456</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkv1145</pub-id><?supplied-pmid 26527722?><pub-id pub-id-type="pmid">26527722</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Wei</surname><given-names>Y</given-names></name>, <name><surname>To</surname><given-names>C</given-names></name>, <name><surname>Zhu</surname><given-names>CQ</given-names></name>, <name><surname>Tong</surname><given-names>J</given-names></name>, <name><surname>Pham</surname><given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact</article-title>. <source>Nat Commun</source>. <year>2014</year>; <volume>5</volume>: <fpage>5469</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ncomms6469</pub-id><?supplied-pmid 25429762?><pub-id pub-id-type="pmid">25429762</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>P</given-names></name>, <name><surname>Hao</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Ma</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Comparative proteomic analysis of polarized human THP-1 and mouse RAW264. 7 macrophages.</article-title><source>Front immunol.</source><year>2021</year>; <volume>12</volume>: <fpage>700009</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2021.700009</pub-id><?supplied-pmid 34267761?><pub-id pub-id-type="pmid">34267761</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Chanput</surname><given-names>W</given-names></name>, <name><surname>Mes</surname><given-names>JJ</given-names></name>, <name><surname>Wichers</surname><given-names>HJ</given-names></name>. <article-title>THP-1 cell line: an in vitro cell model for immune modulation approach</article-title>. <source>Int Immunopharmacol</source>. <year>2014</year>; <volume>23</volume>: <fpage>37</fpage>–<lpage>45</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.intimp.2014.08.002</pub-id><?supplied-pmid 25130606?><pub-id pub-id-type="pmid">25130606</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Hartley</surname><given-names>JW</given-names></name>, <name><surname>Evans</surname><given-names>LH</given-names></name>, <name><surname>Green</surname><given-names>KY</given-names></name>, <name><surname>Naghashfar</surname><given-names>Z</given-names></name>, <name><surname>Macias</surname><given-names>AR</given-names></name>, <name><surname>Zerfas</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>Expression of infectious murine leukemia viruses by RAW264. 7 cells, a potential complication for studies with a widely used mouse macrophage cell line.</article-title><source>Retrovirology.</source><year>2008</year>; <volume>5</volume>: <fpage>1</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1742-4690-5-1</pub-id><?supplied-pmid 18177500?><pub-id pub-id-type="pmid">18177500</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Holman</surname><given-names>JD</given-names></name>, <name><surname>Tabb</surname><given-names>DL</given-names></name>, <name><surname>Mallick</surname><given-names>P</given-names></name>. <article-title>Employing ProteoWizard to convert raw mass spectrometry data.</article-title><source>Curr Protoc Bioinform.</source><year>2014</year>; <volume>46</volume>: <fpage>13</fpage>–<lpage>24</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/0471250953.bi1324s46</pub-id><?supplied-pmid 24939128?><pub-id pub-id-type="pmid">24939128</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Kong</surname><given-names>AT</given-names></name>, <name><surname>Leprevost</surname><given-names>FV</given-names></name>, <name><surname>Avtonomov</surname><given-names>DM</given-names></name>, <name><surname>Mellacheruvu</surname><given-names>D</given-names></name>, <name><surname>Nesvizhskii</surname><given-names>AI</given-names></name>. <article-title>MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry–based proteomics</article-title>. <source>Nat Methods</source>. <year>2017</year>; <volume>14</volume>: <fpage>513</fpage>–<lpage>520</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.4256</pub-id><?supplied-pmid 28394336?><pub-id pub-id-type="pmid">28394336</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><collab>UniProt Consortium</collab>. <article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>; <volume>47</volume>: <fpage>D506</fpage>–<lpage>D515</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky1049</pub-id><?supplied-pmid 30395287?><pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Röst</surname><given-names>HL</given-names></name>, <name><surname>Sachsenberg</surname><given-names>T</given-names></name>, <name><surname>Aiche</surname><given-names>S</given-names></name>, <name><surname>Bielow</surname><given-names>C</given-names></name>, <name><surname>Weisser</surname><given-names>H</given-names></name>, <name><surname>Aicheler</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>OpenMS: a flexible open-source software platform for mass spectrometry data analysis.</article-title><source>Nat Methods</source>. <year>2016</year>; <volume>13</volume>: <fpage>741</fpage>–<lpage>748</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.3959</pub-id><?supplied-pmid 27575624?><pub-id pub-id-type="pmid">27575624</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Uhlén</surname><given-names>M</given-names></name>, <name><surname>Fagerberg</surname><given-names>L</given-names></name>, <name><surname>Hallström</surname><given-names>BM</given-names></name>, <name><surname>Lindskog</surname><given-names>C</given-names></name>, <name><surname>Oksvold</surname><given-names>P</given-names></name>, <name><surname>Mardinoglu</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Tissue-based map of the human proteome</article-title>. <source>Science</source>. <year>2015</year>; <volume>347</volume>: <fpage>1260419</fpage>.<pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>McCarthy</surname><given-names>DJ</given-names></name>, <name><surname>Smyth</surname><given-names>GK</given-names></name>. <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>: <fpage>139</fpage>–<lpage>140</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Hochberg</surname><given-names>Y</given-names></name>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>Journal of the Royal statistical society: series B (Methodological).</source><year>1995</year>; <volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Tyanova</surname><given-names>S</given-names></name>, <name><surname>Temu</surname><given-names>T</given-names></name>, <name><surname>Cox</surname><given-names>J</given-names></name>. <article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title>. <source>Nat Protoc</source>. <year>2016</year>; <volume>11</volume>: <fpage>2301</fpage>–<lpage>2319</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id><?supplied-pmid 27809316?><pub-id pub-id-type="pmid">27809316</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>MY</given-names></name>, <name><surname>Paulo</surname><given-names>JA</given-names></name>, <name><surname>Gygi</surname><given-names>SP</given-names></name>. <article-title>Evaluating false transfer rates from the match-between-runs algorithm with a two-proteome model</article-title>. <source>J Proteome Res</source>. <year>2019</year>; <volume>18</volume>: <fpage>4020</fpage>–<lpage>4026</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00492</pub-id><?supplied-pmid 31547658?><pub-id pub-id-type="pmid">31547658</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Yue</surname><given-names>W</given-names></name>, <name><surname>Sun</surname><given-names>Q</given-names></name>, <name><surname>Landreneau</surname><given-names>R</given-names></name>, <name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Siegfried</surname><given-names>JM</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression</article-title>. <source>Cancer Res</source>. <year>2009</year>; <volume>69</volume>: <fpage>6339</fpage>–<lpage>6346</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0398</pub-id><?supplied-pmid 19584278?><pub-id pub-id-type="pmid">19584278</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref053">
      <label>53</label>
      <mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Duan</surname><given-names>J</given-names></name>, <name><surname>Yuan</surname><given-names>L</given-names></name>, <name><surname>Fan</surname><given-names>S</given-names></name>, <name><surname>Fan</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Enoxaparin Sensitizes Human Non–Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation</article-title>. <source>Mol Pharmacol</source>. <year>2015</year>; <volume>87</volume>: <fpage>378</fpage>–<lpage>390</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1124/mol.114.094425</pub-id><?supplied-pmid 25488183?><pub-id pub-id-type="pmid">25488183</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref054">
      <label>54</label>
      <mixed-citation publication-type="journal"><name><surname>Ori</surname><given-names>A</given-names></name>, <name><surname>Iskar</surname><given-names>M</given-names></name>, <name><surname>Buczak</surname><given-names>K</given-names></name>, <name><surname>Kastritis</surname><given-names>P</given-names></name>, <name><surname>Parca</surname><given-names>L</given-names></name>, <name><surname>Andrés-Pons</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Spatiotemporal variation of mammalian protein complex stoichiometries</article-title>. <source>Genome Biol</source>. <year>2016</year>; <volume>17</volume>: <fpage>1</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">26753840</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>P</given-names></name>, <name><surname>Park</surname><given-names>A</given-names></name>, <name><surname>Han</surname><given-names>G</given-names></name>, <name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Jia</surname><given-names>P</given-names></name>, <name><surname>Zhao</surname><given-names>Z</given-names></name>. <article-title>TissGDB: tissue-specific gene database in cancer</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>; <volume>46</volume>: <fpage>D1031</fpage>–<lpage>D1038</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkx850</pub-id><?supplied-pmid 29036590?><pub-id pub-id-type="pmid">29036590</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Hounkpe</surname><given-names>BW</given-names></name>, <name><surname>Chenou</surname><given-names>F</given-names></name>, <name><surname>de Lima</surname><given-names>F</given-names></name>, <name><surname>De Paula</surname><given-names>EV</given-names></name>. <article-title>HRT Atlas v1. 0 database: redefining human and mouse housekeeping genes and candidate reference transcripts by mining massive RNA-seq datasets</article-title>. <source>Nucleic Acids Res</source>. <year>2021</year>; <volume>49</volume>: <fpage>D947</fpage>–<lpage>D955</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkaa609</pub-id><?supplied-pmid 32663312?><pub-id pub-id-type="pmid">32663312</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><name><surname>Odersky</surname><given-names>M</given-names></name>, <name><surname>Altherr</surname><given-names>P</given-names></name>, <name><surname>Cremet</surname><given-names>V</given-names></name>, <name><surname>Emir</surname><given-names>B</given-names></name>, <name><surname>Maneth</surname><given-names>S</given-names></name>, <name><surname>Micheloud</surname><given-names>S</given-names></name>, <etal>et al</etal>. <source>An overview of the Scala programming language</source>. <year>2004</year>. Available from: <ext-link xlink:href="https://infoscience.epfl.ch/record/52656" ext-link-type="uri">https://infoscience.epfl.ch/record/52656</ext-link>.</mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref058">
      <label>58</label>
      <mixed-citation publication-type="book"><name><surname>Kernighan</surname><given-names>BW</given-names></name>, <name><surname>Ritchie</surname><given-names>DM</given-names></name>. <source>The C programming language</source>. <edition designator="2">2nd</edition>. <publisher-loc>Englewood Cliffs(NJ)</publisher-loc>: <publisher-name>Prentice Hall</publisher-name>; <year>1988</year>.</mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Schoof</surname><given-names>EM</given-names></name>, <name><surname>Furtwängler</surname><given-names>B</given-names></name>, <name><surname>Üresin</surname><given-names>N</given-names></name>, <name><surname>Rapin</surname><given-names>N</given-names></name>, <name><surname>Savickas</surname><given-names>S</given-names></name>, <name><surname>Gentil</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Quantitative single-cell proteomics as a tool to characterize cellular hierarchies</article-title>. <source>Nat Commun</source>. <year>2021</year>; <volume>12</volume>: <fpage>3341</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-021-23667-y</pub-id><?supplied-pmid 34099695?><pub-id pub-id-type="pmid">34099695</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1010961.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Gatto</surname><given-names>L</given-names></name>, <name><surname>Breckels</surname><given-names>LM</given-names></name>, <name><surname>Wieczorek</surname><given-names>S</given-names></name>, <name><surname>Burger</surname><given-names>T</given-names></name>, <name><surname>Lilley</surname><given-names>KS</given-names></name>. <article-title>Mass-spectrometry-based spatial proteomics data analysis using pRoloc and pRolocdata</article-title>. <source>Bioinformatics</source>. <year>2014</year>; <volume>30</volume>: <fpage>1322</fpage>–<lpage>1324</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btu013</pub-id><?supplied-pmid 24413670?><pub-id pub-id-type="pmid">24413670</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pcbi.1010961.r001" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r001</article-id>
    <title-group>
      <article-title>Decision Letter 0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Fraternali</surname>
          <given-names>Franca</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elofsson</surname>
          <given-names>Arne</given-names>
        </name>
        <role>Section Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2023 Fraternali, Elofsson</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Fraternali, Elofsson</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj001" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">15 Nov 2022</named-content>
    </p>
    <p>Dear Dr. Peng</p>
    <p>Thank you very much for submitting your manuscript "ProInfer: An interpretable protein inference tool leveraging on biological networks" for consideration at PLOS Computational Biology.</p>
    <p>As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.</p>
    <p>In particular I would suggest to focus on the issue of false positives raised by the reviewers and the performance comparison with other methods available. In addition is of paramount importance that your tools are accessible and usable without errors, therefore your github repository needs to be updated and kept up to date and flawless.</p>
    <p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p>
    <p>When you are ready to resubmit, please upload the following:</p>
    <p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
    <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
    <p>Important additional instructions are given below your reviewer comments.</p>
    <p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p>
    <p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
    <p>Sincerely,</p>
    <p>Franca Fraternali</p>
    <p>Guest Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Lucy Houghton</p>
    <p>Staff</p>
    <p>PLOS Computational Biology</p>
    <p>***********************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: The authors developed a protein inference tool named ProInfer. The proposed method makes use of prior knowledge from biological networks to improve the performance of protein assembly based on MS data. ProInfer showed superior performance compared to several other publically available tools. The tool was written in Python, and the source code is openly available. The work is of value, and ProInfer can be a valuable tool for proteomic data analysis.</p>
    <p>To make the tool more accessible, especially to colleagues without computational background, I suggest, in addition to releasing the source code, providing a stand-alone version or a web-based application.</p>
    <p>Reviewer #2: ProInfer is a computational analysis framework which infers the identification of proteins from ambiguous peptides identified in mass spectrometry data. The conceptual advance ProInfer provides is incorporating information from protein interaction networks such as CORUM (i.e. protein complexes) to improve the identification of proteins in a given sample. The authors’ compare their method against other protein inference algorithms on a benchmark of Human Protein Atlas validated/unvalidated proteins and show superior recall although limited relative precision. The authors’ also include an analysis of differentially expressed proteins and compare their results to other popular algorithms showing mostly positive performance.</p>
    <p>Major:</p>
    <p>1) Integration of protein complex information to improve protein identification may also introduce bias in the true positives and false positives proteins identified by the method. The authors’ alluded to some of the reasons in their discussion for true positive bias, in particular the incompleteness of biological networks. This however is not the only reason for bias, and I feel a full analysis of the false positives is necessary to give a complete picture.</p>
    <p>One possible source of false positives is partners of proteins that participate in many complexes. It is unclear how these cases are handled in the ProInfer framework. This is a major concern due to the use of maximum probability values. Calmodulin (CALM1), for example, is found in 11 different Human Corum complexes many of them with non-overlapping subunits and unlikely to be expressed all together. If I understand the algorithm correctly, in a scenario where CALM1 is highly (or moderately) abundant in a sample, step 2 will assume all 11 CALM1 containing complexes are present regardless of if the complexes are actually formed, expressed, or seen previously in that cell type/condition. Further in Step 4, using the maximum will transfer the probability of the most confident protein (CALM1 in this case) to all other interaction partners in the 11 complexes regardless of if the individual subunits are expressed or not. This potentially is one source of false positives the method is producing.</p>
    <p>An additional issue that is unclear is how the framework handles paralogous proteins. Paralogous proteins often share the same peptides and can participate as mutually exclusive partners in protein complexes. This method suggests if a partner in a shared complex is present, both paralogous proteins would be identified.</p>
    <p>Due to the above issues and possible other unknown biases, a more complete analysis of the false positives generated by the method is needed and a description of the biases introduced into the identified proteins due to the use of protein complexes as a source of integrated information.</p>
    <p>2) It is unclear how the decoy protein complexes are utilized in the method. It is mentioned but not fully described.</p>
    <p>3) The Human Protein Atlas is used as a benchmark. It is unclear which dataset within the HPA was used. A link to the downloads page would aid in replicability. Further, the description of “validated” vs “non-validated” is vague. What do the authors’ mean by “different tools”? Is it only antibody based methods? Specifics are required for a full evaluation of the method. Publishing the full benchmark in the supplemental along with ProInfer’s identified proteins is necessary as well.</p>
    <p>4) The text states “… literature proofs were searched to prove they really associate with lung cancer.” It is unclear what the criterion is for inclusion here. Many studies have extremely weak associations between genes and diseases and rigorous review of the literature is required to ensure strong evidence of associations. The authors should detail their method and include a supplemental table for the reader to evaluate.</p>
    <p>5) A fresh clone of the github repository does not produce executable code. I received an error when trying the example command: python ProInfer.py ./DDA1.tsv</p>
    <p>NameError: name 'argparse' is not defined</p>
    <p>When I added ‘import argparse’ to the file, I received a different error:</p>
    <p>ProInfer.py: error: unrecognized arguments: ./DDA1.tsv</p>
    <p>Minor:</p>
    <p>Some of the axes in the figures are not labeled properly. For example in Figure 3A-C, the x-axis requires a label.</p>
    <p>Reviewer #3: In this article, the authors present ProInfer, a method that performs protein identification by using an inference method harnessing protein complex information.</p>
    <p>The methods are interesting, and well explained, and the results appear convincing. I have a few comments that I believe should be addressed:</p>
    <p>- the independence assumption in equation 6 seems entirely unjustified, especially if overlapping peptides are considered. Can the authors test that assumption? This directly relates to the next point, since this formula is used for the computation of the FDR:</p>
    <p>- The flat precision curve for ProInfer in figure 2B is puzzling: the precision should go down as the FDR increase. How do the author explain this behaviour?</p>
    <p>- It seems to me that the "reliable" complexes are implicitely given a prior of 1, and the same weight. But different complexes have widely varying concentrations, and confidence. Are they all given the same prior likelihood ?</p>
    <p>- how useful is proinfer when pre-existing identifications of proteins are weaker? for example with less identified proteins in the reference? and how does it affect ProInfer's precision and recall? It seems hard to tell whether ProInfer is efficiently using weak peptide identifications, or using noisy peptide spectra to assign proteins from the network.</p>
    <p>- it would be useful to see a comparison between proInfer and some of the other tools as a function of psm threshold: does proInfer do better than other tools at smaller psm thresholds?</p>
    <p>- It would be nice to have in supplementary some peptide spectra, to illustrate what type of evidence that proInfer uses to draw its inference, that would otherwise be ignored.</p>
    <p>**********</p>
    <p>
      <bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold>
    </p>
    <p>The <ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: <bold>No: </bold>Code is available but does not run without errors. Full results of the code is not provided in the supplementary tables.</p>
    <p>Reviewer #3: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: No</p>
    <p>Reviewer #3: <bold>Yes: </bold>Tristan Cragnolini</p>
    <p>
      <underline>Figure Files:</underline>
    </p>
    <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email>figures@plos.org</email></underline>.</p>
    <p>
      <underline>Data Requirements:</underline>
    </p>
    <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" ext-link-type="uri">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
    <p>
      <underline>Reproducibility:</underline>
    </p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
  </body>
</sub-article>
<sub-article article-type="author-comment" id="pcbi.1010961.r002">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r002</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 0</article-title>
    </title-group>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj002" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">6 Dec 2022</named-content>
    </p>
    <supplementary-material id="pcbi.1010961.s008" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">response_letter.docx</named-content></p>
      </caption>
      <media xlink:href="pcbi.1010961.s008.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pcbi.1010961.r003" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r003</article-id>
    <title-group>
      <article-title>Decision Letter 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Fraternali</surname>
          <given-names>Franca</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elofsson</surname>
          <given-names>Arne</given-names>
        </name>
        <role>Section Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2023 Fraternali, Elofsson</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Fraternali, Elofsson</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj003" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">18 Jan 2023</named-content>
    </p>
    <p>Dear Dr Peng</p>
    <p>Thank you very much for submitting your manuscript "ProInfer: An interpretable protein inference tool leveraging on biological networks" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.</p>
    <p>In particular you should carefully address the requested definition of your approach to defining false positive. Please respond carefully to the suggestions of the reviewer both in the first and second revision,</p>
    <p>Looking forward to your revised manuscript,</p>
    <p>with my best regards</p>
    <p>Franca Fraternali</p>
    <p>Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.</p>
    <p>When you are ready to resubmit, please upload the following:</p>
    <p>[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out</p>
    <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
    <p>Important additional instructions are given below your reviewer comments.</p>
    <p>Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
    <p>Sincerely,</p>
    <p>Franca Fraternali</p>
    <p>Guest Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Lucy Houghton</p>
    <p>Staff</p>
    <p>PLOS Computational Biology</p>
    <p>***********************</p>
    <p>A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact <email>ploscompbiol@plos.org</email> immediately:</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #2: I thank the authors for clarifying some of the points in their manuscript.</p>
    <p>1. I do still have a concern about certain proteins found in many complexes. As mentioned before, some complexes may not be expressed even though a member is highly abundant (CALM1 as an example). This may lead the algorithm to improperly “enhance” the confidence score of a protein associated to a complex that is not expressed. This may be a source of false positives. In the authors’ response, they describe a scenario of two proteins P1 and P2 which have small confidence scores which map to two different complexes associated to CALM1, c1 and c2. P1 and P2 are both enhanced due to their association to c1 and c2. If we additionally know that c2 is not expressed in the tissue of study, P2’s confidence score was then erroneously enhanced. In the described algorithm, this scenario is only problematic with proteins that are found in many complexes such as CALM1.</p>
    <p>A potential test would be to remove all proteins and their complexes from CORUM seen in &gt; 3 complexes and rerun ProInfer. As a control, remove the same number of proteins/complexes that match the average abundances in the first set. This may show if the many complex proteins are having an effect.</p>
    <p>2. The use of the terms “validated” and “non-validated” is confusing as it suggests using additional experimental evidence for validation. Using terms “true-positives” and “false-positives” seems sufficient.</p>
    <p>**********</p>
    <p>
      <bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold>
    </p>
    <p>The <ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
    <p>Reviewer #2: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #2: No</p>
    <p>Figure Files:</p>
    <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com" ext-link-type="uri">https://pacev2.apexcovantage.com</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
    <p>Data Requirements:</p>
    <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" ext-link-type="uri">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
    <p>Reproducibility:</p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
    <p>References:</p>
    <p>Review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.</p>
    <p>
      <italic toggle="yes">If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</italic>
    </p>
  </body>
</sub-article>
<sub-article article-type="author-comment" id="pcbi.1010961.r004">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r004</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 1</article-title>
    </title-group>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj004" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>2</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">30 Jan 2023</named-content>
    </p>
    <supplementary-material id="pcbi.1010961.s009" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">response_letter.docx</named-content></p>
      </caption>
      <media xlink:href="pcbi.1010961.s009.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pcbi.1010961.r005" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r005</article-id>
    <title-group>
      <article-title>Decision Letter 2</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Fraternali</surname>
          <given-names>Franca</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elofsson</surname>
          <given-names>Arne</given-names>
        </name>
        <role>Section Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2023 Fraternali, Elofsson</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Fraternali, Elofsson</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj005" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>2</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">20 Feb 2023</named-content>
    </p>
    <p>Dear Dr Peng,</p>
    <p>We are pleased to inform you that your manuscript 'ProInfer: An interpretable protein inference tool leveraging on biological networks' has been provisionally accepted for publication in PLOS Computational Biology.</p>
    <p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p>
    <p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
    <p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
    <p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
    <p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
    <p>Best regards,</p>
    <p>Franca Fraternali</p>
    <p>Guest Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Lucy Houghton</p>
    <p>Staff</p>
    <p>PLOS Computational Biology</p>
    <p>***********************************************************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #2: The new analysis addresses my concerns regarding false positives introduced by proteins common to multiple complexes. I also feel the revised manuscript is clearer with the additional edits.</p>
    <p>**********</p>
    <p>
      <bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold>
    </p>
    <p>The <ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
    <p>Reviewer #2: None</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #2: No</p>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="pcbi.1010961.r006" specific-use="acceptance-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1010961.r006</article-id>
    <title-group>
      <article-title>Acceptance letter</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Fraternali</surname>
          <given-names>Franca</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elofsson</surname>
          <given-names>Arne</given-names>
        </name>
        <role>Section Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2023 Fraternali, Elofsson</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>Fraternali, Elofsson</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1010961" id="rel-obj006" related-article-type="reviewed-article"/>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">12 Mar 2023</named-content>
    </p>
    <p>PCOMPBIOL-D-22-01320R2 </p>
    <p>ProInfer: An interpretable protein inference tool leveraging on biological networks</p>
    <p>Dear Dr Wong,</p>
    <p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
    <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
    <p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
    <p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
    <p>With kind regards,</p>
    <p>Zsofia Freund</p>
    <p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email>ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link xlink:href="http://ploscompbiol.org" ext-link-type="uri">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
  </body>
</sub-article>
